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5Chapter 1 
GENERAL INTRODUCTION
6This thesis is part of the Behavior and Evolution of Young ONset Dementia part 2 (BEYOND-II) 
study. In this study a multi-component intervention for the management of neuropsychiatric 
symptoms (NPS) in nursing home (NH) residents with young-onset dementia was developed 
and implemented in special care units for people with young-onset dementia.
Young-onset dementia: definition, prevalence, and etiology
Although dementia is considered a disease of old age, in some people first symptoms already 
develop before the age of 65. There is no consensus on the nomenclature concerning these 
younger people with dementia [1]. In the current literature, most commonly the term 
young-onset dementia (YOD) is used [2]. However, confusingly also presenile dementia, 
early onset dementia, and younger onset dementia are often used [1]. Besides discussion 
on the nomenclature, also the cut-off at age 65 is considered arbitrary. This cut-off age is 
related to the social division in terms of employment and retirement age. However, younger 
people with dementia also differ from older individuals with dementia on biological factors 
(e.g. genetics, hereditary patterns, etiology, comorbidities, course of the illness, clinical 
presentation) and other social characteristics (e.g. vitality, social network, family structure, 
day time activities) [1, 3-7]. 
No studies on the prevalence of YOD in the Netherlands have been conducted, 
although these estimates are critical for policymaking and care planning. International 
studies on the prevalence of YOD are scarce. Furthermore, prevalence rates in these studies 
are likely an underestimation as they are based on people who had contact with health 
care services. However, not all people with dementia will seek help early in the course of 
the disease [8]. In the UK the prevalence of YOD was estimated 54.0 per 100,000 [9]. A more  
recent Australian study estimated a higher prevalence of 68.2 per 100,000 [10]. When  
applying these percentages found in the UK and Australia to the Dutch population, this 
would indicate a prevalence between 9,000 and 11,000 individuals with YOD in the  
Netherlands. More research with larger sample sizes is needed to allow for estimates with 
more precision [8].
There is a large variation in the prevalence estimates of the different causes of 
YOD between studies. Overall, Alzheimer’s dementia (AD), as in late-onset dementia (LOD), 
is the most prevalent cause in younger individuals [11]. Nonetheless, the etiology of dementia 
in younger people is more heterogenic: higher proportions of less common causes of  
dementia like frontotemporal dementia (FTD) and alcohol-related dementia have been 
found  [10, 11]. Furthermore, in the youngest individuals, with a disease onset before the age 
of 45 years, it is more likely that a genetic or metabolic disease is causing the dementia [11].
17
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Long-term care in young-onset dementia
Most people with dementia eventually are admitted to NHs. The time from symptom  
onset to institutionalization is more than twice as long for people with YOD (mean 9 years) 
compared to people with LOD (mean 4 years) [12]. This might be related to better physical 
health of the caregivers of younger people with dementia [12]. Also, the limited availability 
of age-appropriate residential care facilities, differences in progression of YOD, and the 
stigma attached to dementia might be explanations [13].
To improve quality of care for people with YOD and their families the Dutch YOD 
Knowledge Center (DKC) was founded in 2001. Currently thirty health care organizations 
as well as several academic centers, general hospitals, and foundations for dementia (e.g. 
FTD lotgenoten, Alzheimer Nederland, Deltaplan dementie) have joined the DKC. The DKC 
develops specific guidelines for YOD, supports scientific research, provides education for 
health care professionals, and promotes the implementation of research findings in clinical 
practice. All affiliated health care organizations provide dedicated YOD services, including 
specialized long-term care units (SCU’s) for people with YOD. In the Netherlands, similar 
to residential care units for elderly people with dementia, care at YOD SCU’s is provided 
by a multidisciplinary team. This multidisciplinary team consists of at least nursing staff, 
psychologist, paramedic disciplines (e.g. physical therapist, speech therapist, occupational 
therapist, dietician) and elderly care physicians [14, 15]. All disciplines are employed by the 
NH, in contrast to most other countries in which these disciplines are not always available 
or only available through consultation of other healthcare organizations [15]. 
Prevalence and management of neuropsychiatric symptoms in young-onset dementia
In the care for NH residents with YOD, high prevalence rates of NPS pose a challenge [16].  
NPS are defined as every form of behavior that results in reduced wellbeing of the resident or 
is considered dangerous for either the residents themselves or others in their surroundings, 
like nursing staff members, clinicians, relatives, or other residents [17]. NPS encompass 
various symptoms such as depression, anxiety, apathy, aggression, agitation, disinhibition, 
delusions, and hallucinations. Mulders et al. (2016) found that NPS occurred in almost all 
NH residents with YOD, with agitation (88%) and apathy (56%) being the most prevalent 
symptoms [16]. Those prevalence rates of NPS seem higher compared to those in LOD 
NH residents [18]. However, the few studies that directly compared rates of NPS between 
young-onset AD and late-onset AD in the community-dwelling population suggest less NPS 
in people with young-onset AD [19-21]. Studies directly comparing NPS in heterogeneous 
samples of NH residents with YOD and LOD are still lacking. Research on NH residents with 
8LOD has shown that NPS are associated with negative health outcomes for the person with 
dementia as well as for health care professionals, such as a loss of quality of life, increased 
cost of care, and high workload for the NH staff [22-24]. These negative health outcomes 
are likely to also apply to YOD. Indeed, van Duinen-van den IJssel et al. (2017) found that 
nursing staff distress is related to NPS in NH residents with YOD [25]. However, to our 
knowledge no studies on other consequences of NPS in residents with YOD have been  
conducted. Psychotropic drugs are often used in the treatment of NPS in dementia, and  
especially in institutionalized people with YOD. Mulders et al. (2016) showed that 87 percent  
used one or more psychotropic drug(s) [16]. Studies on the effect of psychotropic drug 
treatment on NPS in YOD have not yet been performed. Nonetheless, psychotropic drugs 
have been associated with poor health outcomes (like stroke, increased mortality) and 
reduced quality of life in NH residents with LOD [23, 26, 27]. 
The high prevalence rates of NPS and psychotropic drug use (PDU) in YOD stresses 
the importance of successful management of NPS in YOD, in which psychotropic drugs are 
only prescribed if other treatment options have little or no effect. In order to successful 
manage NPS, the underlying causes of NPS needs to be resolved and treated. Cohen-Mans-
field developed the unmet-needs framework [28], in which NPS are perceived as behaviors 
through which the person with dementia might indirectly communicate an underlying 
need. Because of cognitive and functional decline, the person with dementia is less able to 
address and also communicate these needs. These needs can be medical (e.g. physical 
illness, pain, mobility), psychosocial (e.g. life habits, premorbid personality), or  
environmental (e.g. under/over stimulation, behavior of NH staff or other residents) [29, 
30]. Although specific facilities for younger people with dementia are provided in the 
Netherlands, most services are designed for older people and might not always be well 
equipped to address the specific needs of younger individuals, for instance regarding  
daytime activities, social interaction, mobility, and intimate relationships [6]. Therefore, 
people with YOD might be at particular risk for developing unmet care needs.
An intervention for the multidisciplinary team that offers a systematic approach 
in the treatment of NPS taking into account the specific needs of younger individuals is 
lacking. Therefore, in the BEYOND-II study a multi-component intervention which has 
shown effectiveness in the management of NPS in older people with dementia (Grip on 
challenging behavior care program), was adapted to the specific characteristics of NH  
residents with YOD [31, 32]. This intervention provided guidance for the multidisciplinary 
team involved in the management of NPS in NHs (nursing staff, specially trained elderly 
care physicians and psychologists) to structure the process of detection, analysis, treatment, 
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and evaluation of NPS. In order to address unmet care needs and the high prevalence rates 
of PDU in NH residents with YOD, a tool for the detection of unmet needs  [33] and a tool for 
the evaluation of appropriateness of psychotropic drug prescription were [34] added to the 
original intervention. Also an enhanced implementation strategy was designed, based on 
existing knowledge about the implementation of complex interventions in long-term care 
to facilitate implementation in the thirteen participating YOD special care units.
Implementation of interventions in nursing homes
When implementing an intervention in the context of daily practice, researchers are often 
faced with practical difficulties [35]. Contextual factors external to the intervention (like 
staff turnover, organizational changes, staff motivation) could facilitate or hinder  
implementation [36, 37]. Indeed, intervention studies in NHs are often faced with variation 
in adherence of parts of the intervention [38-41]. Potentially effective interventions may fail 
to show effectiveness due to limited implementation. To understand why the intervention for 
the management of NPS in NH residents with YOD was or was not effective, it is important to 
get insight into the degree of implementation and contextual factors influencing  
implementation. Furthermore, reporting on the implementation strategy and how it was 
received provides future users of the intervention with vital information about how to  
reproduce the intervention.
Aims and outline of the thesis 
This thesis is part of the BEYOND-II study. Focus of this thesis is on differences in NPS  
between residents with YOD and LOD, and the consequences of NPS for the quality of life of 
residents with YOD in order to further improve specialized long-term care for younger  
individuals. In addition, the implementation process and effects of a multi-component  
intervention for the management of NPS in institutionalized people with YOD were evaluated.
The following research questions were addressed:
1. What are the determinants of quality of life of NH residents with YOD and are there 
differences between dementia subtypes regarding these determinants? 
 NPS and PDU are associated with a loss of quality of life of NH residents with LOD. 
This negative influence is expected to also apply to YOD, although this has not yet 
been investigated. Insight into the determinants that influence quality of life is  
necessary to improve care and well-being of residents with YOD (Chapter 2).  
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2. Are there differences in NPS between NH residents with YOD and LOD, and can these 
possible differences be attributed to differences in dementia subtype, gender,  
psychotropic drug use, or dementia severity?
 The results of the few studies directly comparing NPS between YOD and LOD are  
inconsistent. In addition, in these studies only people with AD were involved and 
the possible influence of PDU was not taken into account.  
To develop more effective treatments and further enhance NH care for residents 
with YOD, it is important to gain more insight into differences in NPS between  
heterogeneous samples of NH residents with YOD and LOD and the specific  
characteristics of YOD that might contribute to these possible differences (Chapter 3).
3. Are internal and external validity of a multi-component intervention study on the  
management of NPS in NH residents with YOD sufficient and what are barriers and 
facilitators for implementation of the intervention?
 To interpret the effects of the intervention for the management of NPS in YOD 
(Chapter 4), information on validity and degree of implementation is important. 
Furthermore, implementation knowledge is important to optimize implementation 
strategies for future complex interventions in applied NH care. A process evaluation 
which provides knowledge on validity and implementation was performed before 
the effect analysis (Chapter 5). 
4. What is the effect of a multi-component intervention on the prevalence of NPS (particularly 
agitation and aggression) and PDU in residents with YOD compared to care as usual? 
 In order to evaluate effectiveness, the intervention for the management of NPS in 
YOD was implemented on thirteen YOD SCUs. A randomized controlled trial was 
conducted using a stepped wedge design (Chapter 6). 
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Abstract
Aims: The aims of this study are to (1) explore the determinants of quality of life (QoL) in 
nursing home residents with young-onset dementia (YOD), (2) investigate whether there 
are differences between dementia subtypes (Alzheimer’s dementia, vascular/mixed  
dementia, frontotemporal dementia, other) regarding these determinants, and (3)  
compare QoL profiles of YOD nursing home residents across dementia subtypes. 
Methods: This cross-sectional study included 207 nursing home residents. Multilevel 
modeling was used to determine the relationships between QoL and neuropsychiatric 
symptoms (NPS), dementia severity, psychotropic drug use (PDU), dementia subtype, age, 
and gender. Additional multilevel models were used to compare aspects of QoL between 
dementia subtypes. 
Results: Residents’ QoL was negatively associated with advanced dementia, PDU, and 
NPS. In general, the relationships between the determinants and QoL were similar across 
the dementia subtypes. Aspects of QoL differed by dementia subtype. Residents with FTD 
showed less negative emotions, accepted more help and experienced better quality of 
relationships with professional caregivers, had a more positive self-image, felt more  
comfortable in the nursing home environment, and experienced lower quality of social 
relationships.
Conclusions: Considering the high rates of NPS and PDU in YOD residents and their  
negative associations with QoL, we recommend emphasizing services to manage and  
reduce NPS and PDU in nursing home residents with YOD. Furthermore, our findings  
suggest accounting for differences in aspects of QoL by dementia subtype to address  
specific needs and thereby improve QoL.
20
Introduction
Quality of life (QoL) is increasingly recognized as an important measure of general  
well-being in dementia [1]. Therefore, in the past decade, several studies have investigated 
the factors that influence QoL in people with dementia. Better QoL has been associated 
with a reduced awareness of people’s own cognitive deficits and better mental health of 
the caregiver in community-dwelling people with dementia [2,3]. Additionally, the subtype 
of dementia might be associated with QoL. For instance, Bostrom et al. (2007) and Thomas 
et al. (2006) found a significant lower QoL in community-dwelling people with Lewy body 
dementia (LBD) compared to Alzheimer’s dementia (AD) [3,4]. Furthermore, increased  
cognitive impairment and the presence of neuropsychiatric symptoms (NPS) were nega-
tively associated with QoL in both community-dwelling people and nursing home residents 
with dementia [2,3,5-13]. Of the NPS studied, especially depression was strongly  
associated with lower scores of QoL [5,7-11,14-16]. In addition, apathy, psychosis and ag-
itation are negatively associated with QoL [7,10,17]. Moreover, NPS are often treated with 
psychotropic drugs, some of which have also been associated with poor health outcomes 
and reduced QoL in nursing home residents with dementia [5,7,18].
The current knowledge on the determinants of QoL in dementia is largely based 
on research with people with late-onset dementia (LOD). People with young-onset demen-
tia (YOD), defined as dementia with an onset of symptoms before the age of 65 years, often 
encounter specific challenges such as a substantial delay in diagnosis, loss of employment, 
financial issues, social isolation, changes in relationships, and lack of meaningful daytime 
activities, all adding to the negative impact on QoL [19-22]. Indeed, current research  
suggests that younger age is associated with a worse QoL in LOD [9]. Furthermore, NPS are 
very common in nursing home residents with YOD. A recent Dutch study showed that 90% 
of nursing home residents with YOD showed one or more NPS [24,25]. Of the residents, 87% 
used one or more psychotropic drug(s) [24]. These prevalence rates of NPS and  
psychotropic drug use (PDU) seem even higher than in LOD [24,25], placing younger  
nursing home residents with dementia at particular risk of experiencing poor QoL. 
Research on the determinants of QoL in YOD is scarce. One Dutch study found 
that lower levels of QoL in community-dwelling people with YOD were associated with 
higher levels of depression [26]. In that study, no association was found between QoL and 
other NPS or dementia severity. A recent review noted that the studies on QoL in YOD are 
heterogeneous in terms of the included dementia subtypes, which may have a negative  
impact on the consistency of the results [27]. The authors suggest that studies should  
21
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include homogeneous samples to improve the understanding of the determinants of QoL 
in YOD. Moreover, in current research on YOD, unclear definitions of the concept of QoL 
are used, and therefore it is uncertain which specific aspects of QoL were measured [27]. 
The multidimensionality of the QoL construct stresses the importance of investigating QoL 
domains separately to provide clarity regarding the possible differences in specific QoL 
domains and thereby prevent a loss of information [28-30]
A better understanding of the determinants of QoL in YOD and the possible  
differences in QoL across dementia subtypes can improve the care of YOD nursing home 
residents. Therefore, the aims of the current study are to (1) explore the determinants 
(NPS, PDU, dementia subtype, dementia severity, age, gender) of QoL in YOD nursing home 
residents, (2) investigate whether there are differences between dementia subtypes 
regarding the determinants of QoL, and (3) compare the QoL domains of residents across 
the three most common YOD subtypes.
 
Materials and methods
Study design and selection of participants
In this cross-sectional study, baseline data from a larger multicenter study aimed at the 
improvement of the management of challenging behavior in YOD, the Behavior and  
Evolution of Young-ONset Dementia part 2 (BEYOND-II) study, were used. Thirteen YOD 
special care units (SCUs) were recruited through nursing homes that are affiliated with the 
Dutch YOD Knowledge Center (DKC). Residents with a dementia diagnosis with a symptom 
onset before the age of 65 who resided on the SCU for at least one month were eligible 
for inclusion in the study. The exclusion criteria were lack of informed consent, dementia 
caused by human immunodeficiency virus (HIV), traumatic brain injury, Down’s syndrome, 
Korsakov syndrome or Huntington’s disease. The dementia diagnosis was established  
according to the 4th edition of the Diagnostic and Statistical Manual of Mental Disorders, 
text revision 2000 and international accepted criteria for diagnosing dementia subtypes 
were used and were retrieved from medical files [31-36].
The study protocol was approved by the Medical Ethics Committee region  
Arnhem/Nijmegen (file number 2015-1558) and registered in the Dutch Trial Register  
(Trial ID NTR5018). This research project was conducted according to the principles of the 
Declaration of Helsinki (version November 2013, www.wma.net) and in agreement with the 
laws regarding medical-scientific research in humans (WMO).
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Data collection and assessments
Information on in- and exclusion criteria was sent to the participating SCUs for the initial 
selection of residents eligible for the study. The legal representatives of the residents who 
met inclusion criteria were asked for written informed consent. All data were anonymized. 
Trained researchers and research assistants collected the data through structured  
interviews with the nursing staff and from the resident’s medical files. Regular consensus 
meetings with the research team ensured the integrity of the data collection process. 
Quality of life
Quality of life (QOL) was assessed with the Quality of Life in Dementia (Qualidem) questionnaire. 
The Qualidem is an observational instrument and the reliability and validity are satisfactory 
[11,28]. The scale includes 37 items describing observable behavior with four possible  
responses to how often this behavior has been observed in the past week, ranging from  
never to almost daily. The Qualidem consists of nine subscales: Care relationship (ranging from 
0 – 21), Positive affect (ranging from 0 – 18), Negative affect (ranging from 0 – 9), Restless tense 
behavior (ranging from 0 – 9), Positive self-image (ranging from 0 – 9), Social relations (ranging 
from 0 – 18), Social isolation (ranging from 0 – 9), Feeling at home (ranging from 0 – 12), and 
Having something to do (ranging from 0 – 6). A total score is calculated by summing the scores 
of the nine subscales (ranging from 0-111). Higher (sub) scale scores indicate a higher QoL.
Other resident characteristics
NPS were assessed using the Dutch version of the Neuropsychiatric Inventory-nursing 
home version (NPI-NH). The NPI-NH has a high-interrater reliability and has been found to 
be a valid instrument for the assessment of a wide range of NPS in dementia [37,38].  
For each symptom, the Frequency (F) and Severity (S) are rated on a four-point (ranging from 
1-4) and three-point scale (ranging from 1-3). We used NPI-NH factor scores based on a previous 
study in which five NPI-NH factors in a large nursing home sample were found: (1) agitation/ 
aggression, (2) depression (3) psychosis (4) psychomotor agitation and (5) apathy [39].
 Dementia severity was assessed with the Global Deterioration rating Scale (GDS) [40]. The 
GDS is a validated scale that describes seven different stages of dementia ranging from  
“subjectively and objectively normal cognition” to “severe cognitive decline”. The GDS has been 
validated against behavioral, neuro-anatomic and neurophysiologic measures [40]. PDU was  
derived from the nursing homes pharmacists’ electronic files and was classified according to the 
Anatomical Therapeutic Chemical (ATC) classification system into antipsychotics, anxiolytics,  
hypnotics, antidepressants, anti-epileptics, anti-dementia drugs, and any psychotropic medication 
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[41]. Medical and demographic data were extracted from the resident’s medical files. Data on the 
dementia subtype, age, gender, length of stay at the SCU, and date of inclusion were recorded.
Statistical analysis
Analyses were performed using the Statistical Package for the Social Sciences (SPSS) version 
22. Demographic variables (age, gender, length of stay at the SCU, dementia subtype) were 
described by calculating means or proportions. Multilevel modeling (random intercept linear 
mixed model) was used to determine the relationship between the total Qualidem (QoL) score 
as the dependent variable and age, gender, dementia severity (GDS: mild, moderate, severe), 
dementia subtype (Alzheimer’s dementia, vascular/mixed, frontotemporal dementia, other 
consisting of lewy body dementia, Parkinson dementia, alcohol related dementia, neurosyphi-
lis and dementia not otherwise specified), the five separate NPI-NH factor scores (summed FxS 
symptom scores) and PDU (using dichotomous categories: present or absent) as the independent 
variables. The multilevel model corrected for the clustering of residents in the 13 different 
SCUs. The explained variance at the resident level was calculated [42]. To investigate the 
effects of dementia subtype on the relationships between QoL total score and the determinants 
age, gender, dementia severity (GDS: mild, moderate, severe), five NPI-NH factor scores 
(summed FxS symptom scores), and PDU (present or absent), the interaction terms of  
dementia subtype with these determinants were added to the model.
 Furthermore, the estimated marginal means of the Qualidem subscale scores were 
calculated for the dementia subtypes: Alzheimer’s, vascular/mixed, and frontotemporal.  
To compare the estimated means, additional multilevel models were used with the  
Qualidem subscale scores as the dependent variables and dementia severity, age, and 
gender as the independent variables. In all analyses, a 2-tailed P value less than .05 was 
considered statistically significant.
 
Results
Resident characteristics
A total of 207 residents were included. Mean age was 64 years (SD = 6.1), and the male to 
female ratio was approximately equal (Table 1). The majority (61.4%) had severe dementia, 
and most residents were diagnosed with Alzheimer´s dementia (AD) (46.4%). The residents 
had a mean QoL total score of 76.6 (SD = 16.0) and a mean NPS total score of 24.1 (SD = 19.7). 
 Approximately 68% used at least one psychotropic drug.
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Table 1. Demographic and clinical characteristics, Qualidem score, NPI-NH score and 
PDU (n=207)
Resident age at inclusion Mean (SD) 63.9 (6.1)
 [Range] [39-78]
Resident gender Male n (%) 106 (51.2)
Dementia severity (GDS) n (%)
Mild (3,4)  35 (16.9)
Moderate (5)  45 (21.7)
Severe (6,7)  127 (61.4)
Dementia subtype n (%)
Alzheimer’s dementia  96 (46.4)
Vascular dementia  19 (9.2)
Frontotemporal dementia  62 (30.0)
Lewy body dementia  1 (.5)
Parkinson dementia  1 (.5)
Mixed dementia (AD/VaD)  9 (4.3)
Alcohol related dementia  3 (1.4)
Not otherwise specified (NOS)  8 (3.9)
Other cause  8 (3.9)
Quality of life (Qualidem) a Mean (SD)
 [Range]
Care relationship  14.83 (4.6)
  [4 – 21]
Positive affect  13.23 (4.6)
  [0 – 18]
Negative affect  6.49 (2.7)
  [0 – 9]
Restless tense behavior  5.00 (3.0)
  [0 – 9]
Positive self image  8.19 (1.7)
  [0 – 9]
Social relations   9.51 (4.4)
   [0 – 18]
Social isolation   6.69 (2.2)
   [0 – 9]
Feeling at home   10.15 (2.5)
   [2 -12]
Something to do   2.50 (2.2)
   [0 – 6]
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Total score   76.57 (16.0)
   [30 – 111]
Neuropsychiatric symptoms FxS score mean (SD)
(NPI-NH) [Range]
Factor agitation   10.09 (9.8)
   [0 -48]
Factor depression   2.73 (4.9)
   [0 – 24]
Factor psychosis   2.20 (4.2)
   [0 – 21]
Factor psychomotor agitation   4.82 (6.2)
   [0 – 24]
Factor apathy   5.14 (6.1)
   [0 – 24]
Total score   24.09 (19.7)
   [0 - 104]
PDU type of medication n (%)
(ATC code)
Antipsychotic drugs (N05A)   67 (32.4)
Antidepressant drugs (N06A)   73 (35.3)
Anxiolytic drugs (N05B)   57 (27.5)
Hypnotic/sedatives (N05C)  33 (15.9)
Antiepileptic drugs (N03A)  20 (9.7)
Anti-dementia drugs (N06D)  9 (4.3)
At least one PDU  141 (68.1)
aHigher (sub)scores indicate higher QoL
SD: standard deviation; AD = Alzheimer’s dementia, VaD = Vascular dementia;  
PDU = Psychotropic drug use; GDS = Global Deterioration Scale;  
NPI-NH = Neuropsychiatric Inventory-nursing home version;  
ATC code = Anatomical Therapeutical Chemical (ATC) classification
Determinants of quality of life
A multilevel model showed that a low QoL was associated with advanced dementia, PDU, and the 
neuropsychiatric factors agitation/aggression, depression and apathy (Table 2). These variables 
together accounted for 44% of the variance in total QoL score on the resident level.
Furthermore, after adding the interaction terms to the model, a significant  
interaction effect between dementia subtype and the factor psychomotor agitation  
Table 1 (no. 24) continued
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(p = .046) was found. The relationship between the factor psychomotor agitation and QoL 
differed between the AD and the FTD groups. Residents with AD who showed high scores 
on the psychomotor agitation factor experienced a higher QoL (B = .240), whereas residents 
with FTD showing high scores on the psychomotor agitation factor experienced a lower 
QoL (B = -.678). No other significant interaction effects were found.
Table 2.  Multilevel model with significant correlates of QoL
95% CI
B Se B P Lower 
bound
Upper 
bound
Gender (ref. female) -2.27 1.883 .229 -5.985 1.443
Age .240 .152 .099 -.059 .539
PDU (ref. none PDU) -4.863 -1.884 .011* -8.581 -1.145
Dementia subtype (ref. AD) .231
Other -.780 2.925 .790 -6.550 4.990
Vasc./mixed -3.280 2.699 .226 -8.600 2.048
FTD 2.699 2.296 .241 -1.830 7.228
AD 0
Dementia severity (ref. severe) .005*
Mild (3,4) 7.410 2.539 .004 2.400 12.420
Moderate (5) 5.070 2.255 .026 .618 9.515
Severe (6,7) 0
NPI factor agitation -.528 .111 .000** -.745 -.312
NPI factor depression -.670 .204 .001** -1.071 -.265
NPI factor psychosis -.181 .242 .455 -.659 .296
NPI factor psychomotor  
agitation
.042 .159 .793 -.272 .356
NPI factor apathy -.711 .149 .000** -1.006 -.416
* < .05 **<.01
Level-one explained proportion of variance = .430
QoL = Quality of life, Qualidem total score; PDU = Psychotropic drug use;  
AD= Alzheimer’s dementia; Vasc./mixed = Vascular/ mixed dementia;  
FTD = Frontotemporal dementia; NPI-NH = Neuropsychiatric Inventory
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Difference in quality of life domains between dementia subtypes 
The multilevel models showed that residents with FTD scored higher on the ‘Care  
relationship’ subscale than residents with vasc./mixed dementia (mean 16.02 versus 13.26, 
p = .012) (Table 3). The scores on the subscale ‘Negative affect’ were lower in residents with 
AD compared to residents with FTD (mean 5.75 versus 7.02, p = .007). Residents with FTD 
scored higher on the subscale ‘Positive self-image’ compared to residents with vasc./mixed 
dementia (mean 8.49 versus 7.45, p = .012). Additionally, the score on the subscale ´Feeling 
at home´ was higher in residents with FTD than in residents with vasc./mixed dementia 
(mean 10.04 versus 8.67, p = .014). Finally, residents with FTD scored lower on the subscale 
‘Social relations’ than residents with AD (mean 9.77 versus 11.71, p = .005) and with vasc./
mixed dementia (mean 9.77 versus 12.16, p = .007).
Table 3. Differences QoL between Alzheimer’s dementia, Vascular/mixed and  
Frontotemporal dementia groups
AD 
 
(n= 96)
Vasc./
mixed 
(n=28)
FTD 
 
(n= 62)
P 
Qualidem subscale 
scores a
Estimated mean
Care relationship 14.41 13.26 16.02 .030* 
Positive affect 14.53 13.71 12.97 .162
Negative affect 5.75 6.50 7.02 .023* 
Restless tense behavior 5.23 5.61 5.82 .505
Positive self image 7.87 7.45 8.49 .029* 
Social relations 11.71 12.16 9.77 .006** 
Social isolation 6.91 6.57 6.90 .771
Feeling at home 9.78 8.67 10.04 .039* 
Something to do 3.12 3.78 2.97 .140
 
* < .05 **<.01
aHigher subscale scores indicate higher QoL
QoL = Quality of life; AD= Alzheimer’s dementia; Vasc./mixed = Vascular/ mixed dementia; 
FTD = Frontotemporal dementiaAll outcome variables are adjusted for age, gender, and 
dementia severity.
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Discussion
In this study we found that the residents’ QoL was negatively associated with advanced 
dementia, PDU, and the factors agitation/aggression, depression, and apathy. The model 
showed that all the variables included accounted for 44% of the variance in the total QoL 
score. The relationship between QoL and the determinants studied did not differ for dementia 
subtypes, with the exception of the factor psychomotor agitation. Although no association 
was found between overall QoL and dementia subtype, we did find differences between 
residents with AD, vasc./mixed dementia and FTD regarding the separate QoL domains. 
Our findings suggest that the same determinants of QoL in LOD also apply to 
YOD nursing home residents. Advanced dementia was found associated with poor QoL in 
nursing home residents with LOD [12]. Also, similar to our findings, PDU, agitation and  
depression have been found negatively associated with QoL in LOD [7]. Furthermore, in LOD, 
a relationship between poorer QoL and high levels of apathy was found [8]. Therefore, this 
might suggest that the high rates of NPS and PDU found in residents with YOD indeed place 
younger residents with dementia in particular at risk of experiencing poor QoL [24,25].
Furthermore, residents with FTD scored better on four QoL domains. This might 
appear counterintuitive because of the higher levels of agitation, apathy, disinhibition and 
irritability found in FTD [43,44]. An explanation for this finding could be that FTD 
is characterized by an early loss of disease awareness, which has been found to be  
associated with the occurrence of fewer depressive symptoms and might also have a 
positive influence on self-image [45,46]. Our findings are also consistent with a recent 
study on community-dwelling people with YOD, which indicated that people with FTD  
rated their own QoL higher than other subtypes of dementia [26]. Therefore, people with 
FTD might communicate less problems and negative emotions towards health care  
professionals influencing reliability of proxy-reports of their QoL. Furthermore,  
institutionalization provides a structured environment, which might have a particular  
advantage for people with FTD because of the higher levels of apathy found in FTD (41).  
We also found that residents with FTD appeared to experience a lower quality of social 
relationships. This finding could be explained by the higher levels of agitation, apathy,  
disinhibition and irritability found in residents with FTD [43,44], as these characteristics 
might invoke negative reactions from other residents, hinder social interactions and  
therefore result in poorer quality of social relationships.
Several limitations of this study should be considered. We used the total score 
on the Qualidem to reduce the number of tests and therefore diminish the risk of a Type 
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1 error. The use of the Qualidem total score also enabled a comparison of our results with 
those of other studies on the determinants of QoL in LOD using a similar methodology. 
However, we should be aware that using this total score might have resulted in a loss of 
information by not taking into account the multidimensionality of the construct of QoL. 
Another inevitable limitation of this study was the use of proxy reports to investigate  
residents’ QoL. Dröes et al. (2006) found that there were differences in the perspectives on 
QoL between people with dementia and their caregivers [29]. Also, the younger age of our 
residents could have influenced the proxy reports. Nurses might be more inclined to observe 
a lower QoL in YOD, because dementia is considered a disease of old age. Having this  
disease at a younger age might be considered to have a more negative influence on  
wellbeing. However, most residents in this study had advanced dementia. Even when 
sufficient communicative abilities were present, their severe cognitive impairments likely 
would have threatened the validity of self-reported results. Nonetheless, we should be 
aware that the QoL ratings could have been influenced by the professional caregivers’  
attitudes towards the resident and dementia [10,12,16]. Furthermore, we should be aware 
that correlations between the Qualidem subscales and NPI factors could have influenced 
the explained variance to some degree. Also, other factors possibly contributing to the  
QoL of residents with YOD (e.g. nursing home environment, physical impairments, pain, 
frequency of visits from family members) have not been studied. Additionally, the  
residents in this study were only recruited from nursing homes which were affiliated with 
the Dutch YOD Knowledge Center. Therefore selection bias might have taken place possibly 
influencing the external validity of our findings. Finally, some caution should be used when 
interpreting the findings of the subgroup analyses investigating the interaction effects and 
the multilevel models with Qualidem subscale scores as the dependent variables.  
Considering the large number of tests in the analyses, there was a risk of Type 1 error in 
these subgroup analyses this might have been reflected in the differences observed in the 
effects of psychomotor agitation on QoL between dementia subtypes, as there is no  
apparent explanation for this finding. Also, vascular dementia and mixed dementia were 
combined in order to gain statistical power. However, as those dementia subtypes might 
differ in phenomenology, this could have partly influenced the results. Further testing in 
future studies including larger groups of less common diagnoses is necessary to confirm 
the differences in the determinants of QoL and QoL profiles between dementia subtypes 
found in our exploratory analyses. 
This study provides important insight into the determinants of QoL in nursing 
home residents with YOD. The high rates of NPS and PDU in nursing home residents with 
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YOD [24] raise concern given the strong associations found in this study between these 
variables and QoL. Furthermore, our results challenge the existing pharmacological  
interventions in the treatment of NPS, as PDU by itself also is negatively associated with 
QoL in YOD. This finding is in line with other studies on QoL in LOD [7,5,18]. Therefore, in 
the treatment of NPS, the wellbeing of nursing home residents with YOD will probably  
benefit most from non-pharmacological interventions specifically aimed at reducing  
agitation/aggression, depression, and apathy. More research is needed on the influence of 
PDU on QoL in YOD taking into account the specific categories of psychotropic medication 
as well as duration, usage, dose, and causality. 
Additionally, our results suggest that nursing home residents with AD and vasc./
mixed dementia might benefit more from interventions to prevent or diminish the risk of 
experiencing negative emotions (e.g. supporting conversations with a health care  
professional, regular check for depressive symptoms, avoid confrontation with their  
inabilities). On the other hand, in order to improve their quality of social relationships, 
nursing home residents with FTD might benefit from interventions aimed at increasing 
positive social interaction for instance with family, other nursing home residents or  
volunteers. Health care professionals should receive education to raise their awareness 
about the possible differences between dementia subtypes regarding aspects of QoL and 
therewith ensure that they will provide care that meets the specific care needs of all  
diagnostic groups in order to improve residents’ QoL.
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Abstract 
Objective: The aims of the current study are (1) to explore the differences in  
neuropsychiatric symptoms (NPS) between two large samples of nursing home (NH)  
residents with young-onset dementia (YOD) and late-onset dementia (LOD), and (2) to 
investigate whether the possible differences can be attributed to differences in dementia 
subtype (Alzheimer’s dementia, vascular dementia, or other), gender, psychotropic drug 
use (PDU), or dementia severity. 
Method: This is a retrospective cross-sectional study in Dutch long-term care facilities. 386 
NH residents with YOD and 350 with LOD were included. Multilevel modeling was used to 
compare NPS between the groups (YOD versus LOD). Furthermore, dementia subtype,  
gender, PDU, and dementia severity were added to the crude multilevel models to investigate 
whether the possible differences in NPS could be attributed to these characteristics. 
Results: Higher levels of apathy were found in NH residents with YOD. After dementia  
subtype, gender, PDU, and dementia severity were added to the models, also lower levels 
of verbally agitated behaviors were found in YOD compared to LOD. 
Conclusion: Considering the higher levels of apathy found in NH residents with YOD,  
we recommend that special attention be paid to interventions targeting apathy in YOD. 
Although no differences in other NPS were found, the PDU rates were higher in YOD,  
suggesting that the threshold for the use of PDU in the management of NPS is lower.  
This underscores the need for appropriate attention to non-pharmacological interventions 
for the management of NPS in YOD.
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Introduction
Young-onset dementia (YOD) is defined as dementia with symptom onset before the age of 
65. In YOD, neuropsychiatric symptoms (NPS), such as apathy, agitation, aggression, and 
hallucinations, are highly prevalent [1,2]. A recent Dutch study showed that 90% of nursing 
home (NH) residents with YOD had one or more NPS [2]. Previous research in late-onset 
dementia (LOD) has shown that NPS often result in negative health outcomes such as a loss 
of quality of life (QoL), increased cost of care, and high workload for the NH staff [3-5].
People with YOD may have a higher risk of developing NPS compared to people 
with LOD. For example, in the YOD NH population more than half of the residents are male, 
compared to 20% of the residents in the LOD NH population [1,6]. Extreme NPS seem  
especially likely to occur in men below the age of 70 years, as these residents are stronger 
and more vital [7]. Additionally, people with YOD are cared for at home for a longer period 
than people with LOD [8]. Therefore, dementia might be more advanced in NH residents 
with YOD compared to LOD at the time of institutionalization. Increased severity of  
dementia has been linked to more NPS (such as agitation, aggression, and apathy) in NH 
residents with YOD and LOD [2, 9]. In addition, frontotemporal dementia (FTD) is more 
common in YOD; higher levels of agitation, disinhibition, and irritability are found in people 
with FTD than in those with AD, at least in the community-dwelling population [1, 10-12]. 
To develop effective treatment and further enhance care for NH residents with 
YOD, it is important to gain more insight into the differences in NPS between NH residents 
with YOD and LOD and the specific characteristics of YOD that might give rise to these  
possible differences. This insight supports health-care professionals to direct treatment 
and provide care that meets the specific care needs of younger NH residents. 
There have been a few studies that directly compared rates of NPS between YOD 
and LOD. However, these studies did not take into account the possible influence of  
psychotropic drugs, which are often used in the treatment of NPS. Higher rates of  
psychotropic drug use (PDU) are found in NH residents with YOD (87%) than in those with 
LOD (ranging from 63%-75%) [2, 13-15]. Therefore, a greater decline in NPS due to treat-
ment with PDU might be expected in YOD. Furthermore, to our knowledge, all these studies 
involve people with Alzheimer’s dementia (AD), while NPS in other common types of de-
mentia in YOD, such as FTD, were not taken into account. 
In NPS studies directly comparing young-onset AD (YO-AD) and late-onset AD 
(LO-AD), the results suggest less NPS overall in people with YO-AD than in those with LO-AD, 
at least in a community-dwelling population. For instance, Toyota et al. (2007) compared 
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NPS between community-dwelling people with YO-AD and LO-AD and did not find  
differences regarding the prevalence of depressive symptoms and anxiety [16]. Moreover, 
they found fewer delusions and hallucinations as well as less agitation, disinhibition, 
and aberrant motor behavior in YO-AD than in LO-AD. Van Vliet et al. (2012) also found 
lower incidence and prevalence rates of NPS in community-dwelling people with YO-
AD than in those with LO-AD [17]. In addition, Mushtaq et al. (2016) found higher levels 
of delusions, agitation, anxiety, disinhibition and nighttime behavioral disturbances in                             
community-dwelling people with LO-AD than in those with YO-AD [18]. In contrast, the only 
study to our knowledge comparing NPS in YOD and in LOD NH residents found higher levels 
of behavioral symptoms (e.g., waking up at night, aimless wandering, hiding things) in NH 
residents with YO-AD than in residents with LO-AD among people >90 years old [19]. 
The aims of the current study are (1) to explore the differences in NPS between 
two large samples of NH residents with YOD and LOD, and (2) to investigate whether  
possible differences can be attributed to differences in dementia subtype (Alzheimer’s  
dementia, vascular dementia, or other subtypes including FTD), gender, psychotropic drug 
use (PDU), or dementia severity. 
 
Methods
Subjects
This retrospective cross-sectional study is part of the Behavior and Evolution of Young-ONset 
Dementia part 2 (Beyond-II) study, a multicenter intervention study aimed at improving the 
management of NPS in institutionalized people with YOD (N = 203 YOD NH residents) [20].  
Additional baseline data were used from two other longitudinal studies: the Beyond-I study  
(N = 185 YOD NH residents) and the ‘Grip on challenging behavior study’ (N = 362 LOD NH 
residents) [1, 21]. These studies used the same assessment instruments as the Beyond-II study.
In the Netherlands, a large proportion of nursing homes have YOD special care 
units (YOD-SCUs) delivering specialized care for people with YOD. In the YOD group, only 
YOD-SCUs participated. Residents in the YOD group were included in this study if they had a 
dementia diagnosis with symptom onset before the age of 65 and had been residing in the 
YOD-SCU for at least one month before inclusion. The dementia diagnosis was established 
before inclusion in the study according to the 4th edition of the Diagnostic and Statistical 
Manual of Mental Disorders, Text Revision (2000) [22]. In the YOD group, internationally 
accepted criteria for diagnosing dementia subtypes were used [23-27]. The diagnosis was 
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retrieved from the medical file. The exclusion criteria were lack of informed consent,  
dementia caused by human immunodeficiency virus (HIV), traumatic brain injury, Down’s 
syndrome, Korsakoff syndrome, Huntington’s disease, or alcohol-related dementia. In the 
Beyond-II study, informed consent was obtained from the residents’ legal representative 
and the informed consent rate was 88%. In the Beyond-I study, the residents or their legal 
representatives had the possibility to object to participation, resulting in a participation 
rate of 99%. Some YOD-SCUs participated in both the Beyond-I and Beyond-II studies. 
When residents had the same gender, date of birth, and diagnosis, one of them was  
randomly excluded from either the Beyond-I or Beyond-II sample used in this study to  
prevent duplicates.
In the LOD group, participating units for people with dementia (dementia  
special care units, DSCUs) were recruited from NHs that collaborate with the VU University 
Medical Center (Amsterdam) and the Radboud University Medical Center Nijmegen [21]. 
The same inclusion criteria (other than symptom onset before the age of 65) as in the YOD 
sample were applied in this study to obtain homogenous samples. Additionally, residents 
in the LOD group with an age of 70 years or younger were excluded to diminish the risk of 
YOD residents being part of the LOD group. Residents in the YOD group with an age of 70 
years of older were not excluded, because they all had a symptom onset before the age of 
65; therefore, there was no risk that they were part of the LOD group. In the LOD group,  
legal representatives of the residents had the possibility to object to participation,  
resulting in a participation rate of 99%. 
Data collection and assessments
The Beyond-I and Beyond-II study protocols were approved by the Medical Ethics Com-
mittee region Arnhem/Nijmegen. The Grip on challenging behavior study protocol was 
approved by the Medical Ethics Review Committee of the VU University Medical Center. 
This research project was performed according to the principles of the Declaration of Hel-
sinki (version November 2013, www.wma.net) and is in agreement with the law regarding 
medical-scientific research in humans (WMO). Trained researchers and research assistants 
collected the data through structured interviews with the nursing staff and from the res-
ident’s medical files. Respondents were considered reliable if they were the vocational 
nurse specifically assigned to the resident or had regular contact with the resident in the 
past month.
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Outcome measures
Neuropsychiatric symptoms (NPS) were assessed with the Dutch version of the  
Neuropsychiatric Inventory-Nursing Home Version (NPI-NH). The NPI-NH has high  
interrater reliability and has been found to be a valid instrument for the assessment of a 
wide range of NPS in dementia [28-29]. The NPI-NH consists of ten NPS (delusions,  
hallucinations, agitation/aggression, depression, anxiety, euphoria/elation, apathy/ 
indifference, disinhibition, irritability/lability, aberrant motor behavior) and two  
neurovegetative symptoms (nighttime behavior disturbances and appetite/eating  
disturbances). For each symptom, a screening question is used to determine whether the 
symptom is present. If the symptom is present, Frequency (F) and Severity (S) are rated on 
a four-point (ranging from 1-4) and three-point Likert-scale (ranging from 1-3), respectively, 
for each symptom. Scores for each symptom are calculated as F x S. We were interested 
in all NPS, including symptoms with a low frequency or severity and also when symptoms 
were not present. Therefore, we also included symptoms with a low frequency and severity 
in our analyses (instead of focusing on only clinical relevant behavior F x S ≥ 4) and chose 
to score F x S as 0 when a symptom was not present. A total score is calculated by summing 
the F x S scores (ranging from 0 to 144). Five NPI-NH factor scores were calculated by sum-
ming the symptom scores (F x S) included in each factor: (1) agitation/aggression, consist-
ing of the agitation/aggression, euphoria, disinhibition and irritability symptom scores; (2)  
depression, consisting of the depression and anxiety symptom scores; (3) psychosis, 
consisting of the delusion and hallucination symptom scores; (4) psychomotor agitation, 
consisting of the aberrant motor behavior and nighttime behavior symptom scores; and (5) 
apathy, consisting of the apathy and eating disorder symptom scores. These  
neuropsychiatric factors have been found to be relatively consistent in nursing home  
residents with dementia, across different stages of dementia [30].
The Dutch version of the Cohen-Mansfield Agitation Inventory (CMAI-D) was 
used to assess agitation and aggression [31, 31]. The CMAI has well-established validity 
and reliability and assesses 29 agitated or aggressive behaviors [32]. The frequency of each 
symptom is rated on a seven-point scale (range 1-7) ranging from never to several times an 
hour. The total CMAI score ranges from 29 to 203. We used CMAI factors based on a previous 
study in which three CMAI factors in a large NH sample were found: physically non-aggressive 
behaviors (range 7-49), physically aggressive behaviors (range 8-56), and verbally agitated 
behaviors (range 4-28) [33].
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Other measures
Dementia severity was assessed with the Global Deterioration Scale (GDS) [34]. The GDS 
describes seven different stages of dementia on a seven-point scale (1-7), ranging from 
“subjectively and objectively normal cognition” to “severe cognitive decline”. The GDS has 
been validated against behavioral, neuro-anatomical and neurophysiological measures, 
for which significant correlations were found [34].
In addition, data on dementia subtype, age, gender and length of stay at the  
YOD-SCU or DSCU were collected from resident’s medical files. Psychotropic drug use 
(PDU) was derived from the nursing homes pharmacists’ electronic files and was classified 
according to the Anatomical Therapeutic Chemical (ATC) classification system (1997) into 
antipsychotics, anxiolytics, hypnotics, antidepressants, anti-epileptics, anti-dementia 
drugs, and any psychotropic medication [35].
Statistical analysis
All analyses were performed using Statistical Package for the Social Sciences (SPSS) version 
22. Before analysis, the data were checked for missing values. If the proportion of missing 
values in the CMAI total and factor scores was 20% or less, the missing items were replaced 
with the mean of the remaining items. It was not possible to use mean imputation on the 
NPI-NH factor scores, GDS, or PDU, as these scores consisted of less than 5 items, and even 
a single missing value would constitute more than 20% of the items. Therefore, residents with 
missing items on the NPI-NH symptom scores, GDS, and PDU were excluded from analysis.
Demographic variables for both groups (LOD and YOD) were described by  
calculating means or proportions. Multilevel modeling (random intercept linear mixed 
models) was used to compare the mean CMAI total, CMAI factor (physically aggressive  
behaviors, physically nonaggressive behaviors, verbally agitated behaviors), NPI-NH total, 
and NPI-NH factor (agitation, depression, psychosis, psychomotor agitation, apathy) scores 
as dependent variables, with group (YOD versus LOD) as an independent variable.  
Multilevel modeling allows correction for the clustering of residents in different health care 
organizations and therefore also for possible differences in cohorts as each health care  
organization was part of a specific cohort. Furthermore, to investigate whether the possible 
differences could be attributed to differences in dementia subtype (AD, vascular dementia, 
or other subtypes including FTD), gender, psychotropic drug use (using dichotomous  
categories: present or absent), or dementia severity (GDS: mild, moderate, severe), we 
added these variables to the crude multilevel models. 
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Results
Resident characteristics
A total of 736 residents were included, of whom 386 residents had YOD and 350 had LOD. 
In the YOD group, the ratio of males to females was approximately equal (49.5% female), 
in contrast to the LOD group, in which a large majority of subjects were female (73.7%). 
In both the YOD and LOD group, most residents had Alzheimer’s dementia (43.3% in YOD 
and 48.6% in LOD). The second most prevalent dementia subtype was vascular dementia 
(35.1%) in the LOD group and frontotemporal dementia (FTD) (25.1%) in the YOD group. 
In both YOD and LOD, most residents had advanced dementia (62.7% in YOD and 76.8% in 
LOD). Furthermore, psychotropic drug use (PDU) seemed more common in the YOD group 
(76.9% in YOD versus 55.1% in LOD) (Table 1).
Table 1. Demographic and clinical characteristics of the YOD and LOD group
YOD
N = 386
LOD
N = 350
Resident age at inclusion
Mean (SD)
[Range]
62.4 (6.9)
[39-78]
84.43 (6.3)
[71-102]
Resident gender Male n (%) 195 (50.5) 92 (26.3)
Dementia severity (GDS)a n (%)
Mild (2,3,4)
Moderate (5) 
Severe (6,7)
62 (16.1)
81 (21.0)
242 (62.7)
13 (3.7)
66 (18.9)
267 (76.3)
Dementia subtype n (%)
Alzheimer’s disease 167 (43.3) 170 (48.6)
Vascular dementia 56 (14.5) 123 (35.1)
Frontotemporal dementia 97 (25.1) 7 (2.0)
Other 66 (17.1) 50 (14.3)
PDU (at least one) b n (%) 297 (76.9) 193 (55.1)
CMAI total score Mean (SD) 49.60 (18.37) 50.55 (18.21)
CMAI factor scores c Mean (SD)
Physically aggressive behaviors 13.55 (6.51) 13.88 (6.36)
Physically nonaggressive behaviors 14.38 (7.97) 13.87 (7.72)
Verbally agitated behaviors 8.37 (5.99) 9.24 (5.96)
46
NPI-NH total score Mean (SD) 22.84 (17.77) 21.22 (17.80)
NPI-NH factor scores Mean (SD)
Agitation 9.93 (10.21) 9.96 (9.65)
Depression 3.11 (5.17) 4.12 (5.31)
Psychosis 1.79 (3.92) 2.26 (4.37)
Psychomotor agitation 4.84 (6.22) 3.97 (5.47)
Apathy 5.95 (5.97) 3.46 (4.96)
a 1 missing in YOD group, 4 missing in LOD group
b 8 missing in LOD group  
c 1 missing in YOD group, 6 missing in LOD group
SD: standard deviation, GDS = Global Deterioration Scale, PDU = Psychotropic Drug Use, 
CMAI = Cohen-Mansfield Agitation Inventory, NPI-NH = Neuropsychiatric Inventory-nursing 
home version.
Differences in NPS between YOD and LOD
The unadjusted multilevel models showed that residents with YOD had higher mean  
NPI-NH apathy factor scores than residents with LOD (p < .001, B = 2.612) (Table 2, model 1). 
No other statistically significant differences were found on either the NPI-NH or the CMAI 
factor scores. After entry of PDU, gender, dementia severity and dementia subtype into the 
multilevel models, significant differences in both the apathy score (p < .001 B = 2.794) and 
the mean CMAI verbally agitated behaviors factor score were found (p = .023, B = -1.403) 
(Table 2, model 2). Residents with YOD had lower mean CMAI verbally agitated behaviors 
factor scores compared to residents with LOD.
Table 1 (no. 45) continued
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Table 2. Multilevel models with differences between groups (YOD / LOD) on NPS 
with no correction (Model 1), and correction for gender, PDU, dementia severity, 
and dementia subtype (Model 2).
Model 1 Model 2
95% CI 95% CI
B P Lower bound
Upper 
bound B P
Lower 
bound
Upper 
bound
CMAI total  
score
-.316 .900 -5.386 4.753 -1.480 .544 -6.365 3.406
CMAI factor  
scores
Physically  
aggressive  
behaviors
-.236 .766 -1.833 1.361 -.234 .751 -1.711 1.243
Physically  
nonaggressive  
behaviors
.761 .440 -1.22 2.743 .426 .673 -1.510 2.451
Verbally  
agitated  
behaviors
-.827 .115 -1.865 .211 -1.403 .023* -2.600 -.206
NPI-NH total  
score
2.047 .342 -2.271 6.364 1.597 .444 -2.573 5.766
NPI-NH factor  
scores
Agitation/ 
Aggression
.061 .943 -1.658 1.780 -1.002 .270 -2.478 1.036
Depression -.972 .117 -2.201 .258 -.710 .221 -1.866 .446
Psychosis -.419 .387 -1.393 .555 -.490 .341 -1.519 .539
Psychomotor  
agitation
.988 .143 -.349 2.324 .708 .335 -.761 2.178
Apathy 2.612 .000** 1.251 3.972 2.794 .000** 1.502 4.086
* < .05 **<.01
CMAI = Cohen-Mansfield Agitation Inventory; NPI-NH = Neuropsychiatric Inventory-nursing 
home version; PDU = Psychotropic drug use
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Discussion
In this study, the differences in NPS between heterogeneous samples of  NH residents with 
YOD and LOD were investigated. Higher levels of apathy were found in NH residents with 
YOD compared to LOD. Furthermore, after corrections were applied for gender, PDU, de-
mentia severity, and dementia subtype, higher levels of verbally agitated behaviors were 
found in LOD than in YOD. 
In line with our findings, Cohen-Mansfield and Libin (2005) found that higher 
levels of verbal agitation were associated with older age [36]. An explanation could be that 
with advanced age, more physical impairments are likely to occur, hindering activities in 
daily life. This likely results in feelings of frustration and as a consequent an increase in 
verbally agitated behaviors in response to the high levels of physical impairment. Higher 
rates of verbal aggression in LOD were only found in our study after taking into account the 
influence of possible confounders (gender, PDU, dementia subtype, dementia severity). 
An explanation could be the higher prevalence of residents with less advanced dementia 
in the YOD group, as verbally agitated behavior is less prevalent in advanced dementia [2]. 
Furthermore, we did not find differences in the CMAI total or other factor scores, which 
supports the notion that agitation is a multidimensional construct consisting of different 
aspects that should be taken into account in further research in order to prevent loss of 
information.
We found higher levels of apathy in NH residents with YOD than in those with 
LOD. This might be partly explained by the high prevalence in YOD of FTD, in which higher 
rates of apathy have been found compared to AD [12]. However, these differences were 
still strongly significant after dementia subtype was corrected for, suggesting that higher 
rates of apathy exist in NH residents with YOD, irrespectively of dementia subtype. Another 
explanation might be that the frequency and severity of the NPS (including apathy) were 
rated by nursing staff members. Nurses might observe apathy in LOD less often because 
they might perceive the inactivity as part of older age. Although apathy is often not expe-
rienced as disturbing by nursing staff, the higher rates found in NH residents with YOD still 
raise concern because of the strong negative association between apathy and quality of life 
in NH residents with YOD [37, 5]. Therefore, special attention needs to be directed to inter-
ventions targeting apathy in NH residents with YOD.
Although we did not find any additional differences in NPS between the two 
groups, the PDU rates in YOD seemed higher than those of the LOD group (77% in YOD 
versus 55% in LOD). This suggests that the threshold for the use of psychotropic drugs in 
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the management of NPS is lower in YOD. An explanation for the higher levels of PDU in YOD 
could be that the same behaviors in younger individuals are perceived as more threaten-
ing or distressing by the nursing staff. Consequently, physicians might be more inclined to 
prescribe psychotropic drugs in YOD than in LOD [38]. In future studies, further testing is 
needed on differences in distress experienced by YOD and LOD nursing staff in response to 
residents’ NPS.
Several limitations of this study should be considered. We chose to use factor 
scores instead of symptom scores on the NPI-NH in order to reduce the number of tests in 
the analyses and thereby diminish the risk of a Type 1 error. Additionally, we used factor 
scores of the CMAI instead of the total score to provide clarity regarding the possible differ-
ences in specific aspects of aggression and thereby prevent a loss of information. However, 
the factor structure of both the NPI-NH and CMAI was evaluated in older NH residents with 
dementia and has not yet been established in YOD [30, 33]. Furthermore, part of the YOD 
group was drawn from an older cohort. There is a possibility that there are differences 
within these cohorts (for example, due to changes in the health care system), for which we 
partly corrected with the use of the multilevel models. At last, we cannot confirm that the 
international accepted criteria for diagnosing dementia subtypes were used in all residents 
part of the LOD group.
 
Conclusion
This study provides important insight into the differences in NPS between NH residents 
with YOD and LOD. The higher rates of apathy found in NH residents with YOD raise concern 
because of the strong negative association between apathy and quality of life [37]. There-
fore, in order to improve care, we recommend that special attention be paid to interven-
tions targeting apathy in NH residents with YOD. For example, especially for NH residents 
with YOD, it might be important to provide a stimulating socio-therapeutic environment 
and to facilitate social engagement and activities of daily living. Further research is needed 
to gain insight into possible biological or psychosocial influences underlying the differenc-
es in apathy between NH residents with YOD and LOD. 
Although NH residents with YOD were no more likely than those with LOD to 
develop NPS other than apathy, residents with YOD still received psychotropic drugs more 
often in the treatment of NPS. This underscores the need for appropriate attention to effec-
tive non-pharmacological interventions for the management of NPS in YOD.
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Abstract  
     
Background: Both neuropsychiatric symptoms (NPS) and psychotropic drug use are  
common in institutionalized People with Young Onset Dementia (PwYOD) and can produce 
negative outcomes such as reduced quality of life and high workload. In community-dwelling 
PwYOD, NPS are found to be associated with unmet care needs. This emphasizes the  
importance of a care program for the management of NPS in institutionalized PwYOD that 
also addresses unmet care needs and psychotropic drug use. The objectives of the  
Behavior and Evolution of Young ONset Dementia part 2 (BEYOND-II) study are to develop 
a care program for the management of NPS in institutionalized PwYOD and to evaluate its 
effectiveness. 
Methods: The care program consists of an educational program combined with an  
intervention to manage NPS with the following five steps: the evaluation of psychotropic 
drug prescription, detection, analysis (including the detection of unmet needs), treatment 
and the evaluation of NPS. A stepped wedge design will be used to evaluate its effectiveness. 
The primary outcomes are agitation and aggression and other NPS. The secondary  
outcomes are psychotropic drug use, quality of life, the workload of nursing staff and job 
satisfaction. Additionally, a process analysis and a cost-consequence analysis will be  
conducted. 
Conclusions: The study protocol of the Beyond-II study describes the development,  
implementation and evaluation of a care program for the management of NPS in  
institutionalized PwYOD. This care program provides a structured method for the  
management of NPS, in which unmet needs and psychotropic drug use are also addressed.
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Introduction
In approximately 6-9% of all people with dementia the first symptoms develop before the 
age of 65 [1]. This so-called young onset dementia (YOD) poses challenges that are  
specifically related to the particular life phase in which the dementia occurs, such as a 
delay in obtaining a diagnosis and a consequential delay in the initiation of appropriate 
care and support [2,3]. Furthermore, people with YOD (PwYOD) have specific needs that are 
frequently unmet; these needs involve day-time activities, social interaction and mobility 
[4]. In community-dwelling PwYOD these unmet care needs have been found related to the 
onset of, and increase in neuropsychiatric symptoms (NPS). This finding emphasizes the 
importance of addressing unmet care needs in care programs for NPS in order to improve 
the management of these behaviors in PwYOD [4].
NPS such as agitation, apathy or depression are common in PwYOD and can be 
burdensome for the person with dementia and/or the environment (e.g., nursing staff,  
informal caregivers, other residents). A recent Dutch study found that 88% of the  
institutionalized PwYOD showed clinically relevant NPS, with agitation and apathy being 
the most prevalent symptoms [5,6]. This prevalence rate could be related to the high  
proportion of people with frontotemporal dementia, in which NPS is the most predominant 
symptom [5-7]. Furthermore, 50% of institutionalized PwYOD are men, and research shows 
that extremely NPS and agitated and aggressive behaviors are more likely to occur in men 
below the age of 70 [8].
NPS in late onset dementia (LOD) are associated with negative health outcomes 
for the person with dementia as well as for healthcare professionals. These outcomes  
include reduced quality of life (QoL), increased healthcare costs and increased nursing 
staff burden [9-12]. These negative health outcomes could also apply to YOD. Moreover, 
compared to LOD, nurses caring for PwYOD are presumably more often confronted with 
severe or extreme NPS, especially given the higher prevalence of aggressive behavior in 
PwYOD [5]. In particular, agitated and aggressive behavior appears to be strongly related 
to perceived burden [12]. It is likely that these behaviors will increase both the burden and 
workload of nurses caring for PwYOD and have a negative impact on their feelings of  
competence. Additionally, it is possible that the impact of NPS lowers the threshold for the 
use of psychotropic drugs for treatment. Indeed, Mulders et al. (2016) found that in YOD 
87.6 % of residents used one or more psychotropic drug(s) [5]. This is concerning because, 
even though psychotropic drugs can be effective in reducing NPS, they are also associated 
with negative health outcomes and reduced QoL [11, 13, 14]. Other studies have shown 
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that non-pharmacological interventions with less adverse effects are also effective in the 
management of NPS [15-17]. Therefore, the high prevalence rates of NPS and psychotropic 
drug use (PDU) in institutionalized PwYOD and the negative consequences for residents 
and nursing staff stresses the importance of the systematic non-pharmacological  
management of NPS. 
The “Grip on challenging behavior” care program has shown effectiveness in the 
management of NPS in dementia [18, 19]. The Grip care program is based on the generic 
guidelines for the management of NPS in dementia for the professionals most involved in 
the care of institutionalized people with dementia: nursing staff, elderly care physicians 
and psychologists [20-23]. The care program consists of a comprehensive educational 
program combined with a systematic intervention with the following four steps to manage 
NPS namely, the detection, analysis, treatment and evaluation. However, this care program 
is mainly developed for LOD and does not specifically focus on YOD. Therefore, it does not 
address the possible factors related to a younger age in the management of NPS, such 
as the different care needs of these younger individuals and the high levels of PDU [4,5]. 
However, the Grip care program offers a promising starting point for the development of a 
care program to manage NPS in PwYOD. Furthermore, this care program has proven to be 
effective in decreasing the prevalence of NPS and PDU and in increasing job satisfaction of 
the nursing staff [24-25]. 
Aim and research questions
The Behavior and Evolution of Young ONset Dementia part 2 (BEYOND-II) intervention 
study aimed to improve the management of NPS in YOD by researching the effects of a 
newly developed multi-component care program in institutionalized PwYOD. The care 
program will be based on the ‘Grip on challenging behavior’ care program. The current  
paper describes the design of a trial to investigate the effects of the care program, a  
process evaluation to investigate the implementation of the care program, and a  
cost-consequence analysis to estimate the monetary value of the care program. Based on 
previous research on the management of NPS in people with LOD, we expect that the care 
program will result in a decline in NPS and a decrease in the use of psychotropic drugs.
The research questions are as follows:
(1) What is the effect of the care program on the prevalence and severity of NPS, particularly 
agitation and aggression, compared to care as usual in YOD Special Care Units (SCUs)?
(2) What is the effect of the care program on PDU and QoL of institutionalized PwYOD? 
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(3) What is the effect of the care program on nursing staff in terms of workload, absenteeism 
and job satisfaction?
(3) Was the care program implemented as planned?
(4) What are cost-consequences of the implementation of the care program?
Methods
Development of the care program
The care program in this study is based on the ‘Grip on challenging behavior’ care program, 
that consists of an educational program followed by the implementation of four  
consecutive steps: detection, analysis, treatment and evaluation of NPS. At the start of the 
implementation of the ‘Grip on challenging behavior’ care program all staff (nurses,  
elderly care physicians and psychologists) in the SCU received an educational program 
that consists of two training sessions in which causes and mechanisms of NPS were  
discussed and the use of the care program was explained. Six months after implementation 
all staff received a retraining to enhance implementation of the care program. The ‘Grip on 
challenging behavior’ care program is described in detail elsewhere [18]. 
The educational program was tailored by the researchers to the specific 
(clinical) characteristics and context of YOD. In the Netherlands, nurses are generally only 
educated in dementia care which does not cover YOD specific issues. The educational  
program was adapted in consultation with health care psychologists and elderly care  
physicians working in YOD SCUs. The adapted educational program for the SCU staff covers 
YOD in general as well as factors influencing the occurrence and persistence of NPS in YOD 
and the (steps of the) care program.
The four steps of the ‘Grip on challenging behavior’ care program remained the 
same. However, the evaluation of appropriateness of psychotropic drug prescription was 
added to the care program as a separate step and also a tool for the detection of unmet 
needs was added to the analysis step of the care program. The tool for the evaluation of 
appropriateness of psychotropic drug prescription is based on the Appropriateness of  
Psychotropic Drug Prescription In Dementia (APID)-instrument [26-27]. The APID is a  
research tool for evaluating the appropriateness of psychotropic drug prescription  
prescribed for NPS in patients with dementia in nursing homes. The APID tool was  
transformed into a self-evaluation tool for use by the elderly care physician. This was done 
in consultation with the developers of the APID-instrument. A pilot was held in the LOD 
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SCUs of two nursing homes. The results from the pilot were then discussed in a consensus 
meeting with the developers of the APID-instrument. The tool for the evaluation of  
appropriateness of the psychotropic drug prescription was adapted based on the results of 
this consensus meeting. 
The tool for the detection of unmet needs is based on the Dutch version of the 
Camberwell Assessment of Need for the Elderly (CANE) [28-29]. The CANE is a  
semi-structured interview that covers the needs of people with dementia. Panel group 
discussions with health care professionals and researchers with experience working with 
PwYOD were used to adapt the CANE to the specific areas of needs of institutionalized 
PwYOD. Additionally, the assessment of the CANE was adapted for observational use, 
allowing for use and interpretation by nurses as a part of the care program. A pilot study 
was held in a YOD SCU that did not participate in the overall study. The usability of the tool 
was evaluated using semi-structured qualitative interviews with nurses, PwYOD residing in 
the SCU, and informal caregivers. The tool for the detection of unmet needs was adapted 
based on the results of this pilot.
The ‘Grip on challenging behavior’ care program was originally on paper.  
Currently, in most Dutch nursing homes electronic client files are used. Therefore, the care 
program is fully digitalized. All elements of the care program are integrated in a web based 
environment which makes it possible for the SCU team to have direct access to the care 
program. Also automated notifications can be sent to all involved disciplines.
Intervention
After the above mentioned adaptations, the intervention offered to the SCUs consists of an 
educational program followed by the implementation of the five-step care program on the 
management of NPS. The steps of the care program are described in Figure 1. The first step 
of the care program is the evaluation of appropriateness of psychotropic drug prescription. 
This is a separate step, the other four steps are consecutive and form a cycle. This step 
involves using the tool for the evaluation of appropriateness of psychotropic drug  
prescription. This will be completed for all residents by the elderly care physician in the 
first two months after the SCU is enrolled in the intervention condition. After the initial 
screening, the elderly care physician can consider psychotropic drug prescription monitoring 
with the self-evaluation tool at his own discretion. Detection of NPS, can occur in usual 
(daily) observations or with the screening tool for the detection of NPS. Residents are  
systematically screened every six months for NPS by the nurses with the screening tool 
as part of the care program. After detection, (symptoms of) NPS are analyzed by the 
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nurses. The analysis contains questions about the behavior (e.g., describe the behavior, 
describe the frequency) and includes the tool for the detection of unmet needs in order to 
investigate whether unmet needs could be a cause of NPS. If necessary, the elderly care 
physician or psychologist continues the analysis. The outcome of the analysis is discussed 
in multidisciplinary meetings. After the analysis, the options for treatment are discussed, 
and the treatment plan is established. The treatment plan contains a specifically defined, 
measurable treatment goal. Psychosocial treatments are preferred; psychotropic drugs are 
prescribed only if psychological treatment has little or no effect. The last step is the  
evaluation of the treatment. The frequency and severity of NPS before and after treatment 
are compared. When treatment outcomes are unsatisfactory, other treatments are  
considered, or the analysis is performed again. 
Figure 1. The five steps of the care program ‘Grip on NPS in institutionalized PwYOD’.
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Design
A stepped wedge design (Table 1) will be used to evaluate the effectiveness of the care  
program. This design allows clusters (in this case, YOD SCUs) to cross-over from a control to 
an intervention condition over time and assures that all clusters receive the care program 
and can benefit from the possible positive effects of the intervention [30]. This increases 
the motivation of care organizations to participate in the study. Also, a stepped wedge 
design is considered appropriate when there are practical and logistic constraints to  
implementing the intervention simultaneously to all participants in the intervention  
condition, which is applicable to this study [30]. Moreover, a stepped wedge design increases 
the study power by enabling analyses between and within groups [31]. In this study, YOD 
SCUs from nursing homes throughout the Netherlands will be included. The YOD-SCUs will 
be randomly assigned to one of three groups. There will be four assessments at six month 
intervals during a period of 18 months. After each assessment, a new group will enter the 
intervention condition. The control condition will consist of care as usual without the  
educational program and use of the care program. 
Table 1. Stepped wedge design
Cluster 1 Cluster 2 Cluster 3
T0 0 0 0
T1 1 0 0
T2 1 1 0
T3 1 1 1
0 = control condition; 1= intervention condition
There are four, half yearly, assessments. Each cluster consists of four or five YOD-SCUs
Participants
Eligible YOD SCUs will be recruited through nursing homes that are affiliated with the Dutch 
YOD Knowledge Center (DKC). PwYOD who have a diagnosis of dementia with symptom onset 
before the age of 65 and who have been residing in the SCU for at least one month will be 
included in the study. Diagnoses of dementia subtype will be made according to the regular 
criteria and retrieved from the medical file [32-37]. People with dementia caused by human 
immunodeficiency virus (HIV), traumatic brain injury, Down syndrome, Korsakov or  
Huntington’s disease will be excluded. All nurses employed in the YOD SCU will be included 
in the study.
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Power calculation
In the power calculation, a 6.8 decrease in NPS as measured with the Cohen-Mansfield  
Agitation Inventory (CMAI) is considered a clinically relevant effect of the care program. 
This value corresponds to the 0.4 SD of the CMAI (mean 48.8 (16.7)) of the Beyond-I study 
[6]. We assume an ICC of 0.1, which is based on a Dutch study of institutionalized people 
with LOD [38]. Based on these assumptions, a significance level (alpha) of 0.05 and a power 
(beta) of 0.80, 10 YOD SCUs with 20 people each in three groups with four measurements 
are needed for this study. No further attrition is expected because newly admitted residents 
will replace those who are discharged or die during the study. However, it is possible that 
an SCU will drop out, for example, due to relocation or organizational problems. Therefore, 
13 YOD SCUs will be recruited.
Outcome measures
Primary outcomes
Agitation and aggression will be assessed with the Dutch version of the Cohen-Mansfield 
Agitation Inventory (CMAI-D) [39,40]. The CMAI is the only instrument that specifically  
addresses agitation and aggression that has been translated into Dutch and has  
well-established validity and reliability [40, 41]. The CMAI-D assesses 29 agitated or  
aggressive behaviors. The frequency of each symptom is rated on a seven-point 
Likert-scale (1-7) ranging from never to several times an hour. A total sum score (range  
29-203) can be calculated as well as a score for the subscales of physically nonaggressive 
behavior, physically aggressive behavior and verbally agitated behavior [42]. 
Other NPS will be assessed with the Dutch version of the Neuropsychiatric  
Inventory-Nursing Home version (NPI-NH) [43-44]. The NPI-NH has a high-interrater  
reliability and has been found to be a valid measure for NPS [43]. The NPI-NH contains 
twelve neuropsychiatric symptoms. For each symptom, a screening question will be used 
to determine whether the symptom is present. For each symptom, Severity (S) and  
Frequency (F) will be rated on three-point (1-3) and four-point (1-4) Likert-scales,  
respectively. Additionally, the occupational disruptiveness of symptoms will be assessed 
on a six-point Likert-scale ranging from no distress to extreme distress (0-5). Scores for 
each symptom are calculated as F multiplied by S (range 1-12), and a total score can be 
calculated by summing the FxS scores ranging from 0 (symptom was absent) to 144. A total 
score for occupational disruptiveness can be calculated by adding each score (range 0-60). 
For an overview of all measurements, see Table 2.
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Secondary outcomes: institutionalized PwYOD
QoL will be assessed with the Quality of Life in Dementia (QUALIDEM) questionnaire 
[45,46]. The Qualidem is a 37-item behavior observation scale for people with dementia 
in residential care. Nursing staff rate the Qol for the PwYOD over the preceding week on a 
four-point scale, ranging from never to almost daily. The Qualidem has nine subscales: care 
relationship, positive affect, negative affect, restless tense behavior, positive self-image, 
social relations, social isolation, feeling at home and having something to do. 
Dementia severity will be assessed with the Global Deterioration Scale (GDS) 
[47]. The GDS is a validated seven-point scale that describes seven different stages of  
dementia ranging from ‘no impairment’ to ‘very severe cognitive impairment’.
PDU will be derived from the nursing home pharmacist’s electronic registration 
system and will be classified according to the Anatomical Therapeutic Chemical (ATC)  
classification system into groups of antipsychotics, anxiolytics, hypnotics, antidepressants, 
antiepileptic drugs and cholinesterase inhibitors [48]. 
Secondary outcomes: nursing staff
Workload will be assessed with the Dutch version of the Maslach Burnout Inventory, known 
as the Utrecht Burnout Scale (UBOS) [49,50]. The UBOS is a 20-item questionnaire assessing 
three components of burnout: emotional exhaustion, depersonalization and decreased 
personal accomplishment. Questions will be answered on a seven-point scale ranging from 
‘never’ to ‘always’. 
Job satisfaction and job demands will be assessed with two subscales of the 
Leiden Quality of Work Questionnaire (LQWQ) [51]. The LQWQ assesses the nursing staff’s 
perception on their quality of work. The two subscales assess ‘job satisfaction’ and ‘job 
demands’ with six and seven items, respectively. Questions are answered on a four-point 
Likert scale ranging from ‘totally disagree’ to ‘totally agree’. 
The staffs attitude towards dementia and dementia care will be assessed with 
the Approaches to Dementia Questionnaire (ADQ) [52]. 
Other PwYOD and nursing staff characteristics 
The sex, age, and length of stay of the resident will be obtained from the medical file.  
The age, sex, years of working experience, educational level, and weekly working hours of 
the nursing staff will also be assessed through a questionnaire. Additionally, staff  
absenteeism will be obtained from periodical registrations done by the Human Resources 
department of the nursing home.
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Special care unit characteristics
Characteristics of the SCU will be registered, including the care concept used at the SCU, the 
living environment (small scale/ traditional long term care) and the nursing staff-resident 
ratio. This will be completed through structured telephonic interviews with the site  
coordinator of the study.
Table 2. Flowchart of measures used during the assessments
Outcome  
measure
Operationalization  
(Type of instrument)
Time of assessment
PwYOD S T0 T1 T2 T3
Primary outcome
Agitation and  
aggression
CMAI-Da (SI) f f f f
Frequency and  
severity of  
neuropsychiatric  
symptoms
NPI-NHb (SI) f f f f
Secondary  
outcome
Quality of life Qualidemc (SI) f f f f
Severity of  
dementia
GDSd (RS) f f f f
Psychotropic  
drug use
ATC code, dose,  
frequency 
f f f f
Additional  
variables
Inclusion/  
exclusion criteria
ecp/p ecp/p ecp/p ecp/p ecp/p
Demographic data Age, sex, length of stay f f f f
Medical record  
investigation
Current dementia  
diagnosis, comorbidity
f f* f* f*
Nursing staff
Secondary  
outcome
Workload UBOSe (Q) n n n n
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Job satisfaction ‘Job satisfaction’ and 
‘Work/time pressure’ of 
the Leiden Quality of Work 
Questionnaire f(Q)
n n n n
Absence rate Periodical registrations of the 
NH personnel departments
e e e e
Additional  
variables
Nursing staff  
attitude
ADQg (Q) n n n n
Demographic data Age, sex, educational level, 
years of working experience
n n n n
YOD SCU
Care concept Three item questionnaire 
on the extent to which a 
specific care concept is  
implemented at the SCU (SI)
e e e e
Nursing staff/  
resident ratio
e e e e
Living  
environment
e e
a (Cohen-Mansfield et al., 1989)
b (Wood et al., 2000)
c(Ettema et al., 2007a; b)
d(Reisberg et al., 1982)
e(Maslach, 1986)
f(Van der Doef and Maes, 1999)
g(Lintern, 2001a)
S = Screening; T0-T3 = measurements 0-3; SI = Structured Interview; RS = Rating Scale;  
Q = questionnaire; f = informant is first responsible nurse; ecp = informant is elderly care 
physician; p = informant is psychologist; n = informant is nurse; e = informant is manager or 
employee of personnel department of the nursing home. 
 
 
Table 2 (no. 66) continued
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Ethical considerations
The study protocol has been approved by the Medical Ethics Committee region Arnhem/
Nijmegen (file nr: 2015-1558). This research project will be completed according to the 
principles of the Declaration of Helsinki (version November 2013, www.wma.net). Written 
informed consent will be obtained from the legal representative of each resident, and all 
data will be anonymized. 
Procedures 
Information on the inclusion and exclusion criteria will be sent to the participating  
YOD-SCUs. Only the legal representatives of institutionalized PwYOD who meet the  
inclusion criteria will receive written information and will be asked for their informed 
consent to participate. Informed consent will be requested for information retrieval from 
the medical file and for proxy assessments. After written informed consent is received, the 
researchers will contact the nursing staff to arrange the assessment interview. All resident 
outcomes will be assessed through interviews with the nursing staff. Respondents will be 
considered reliable if they are the vocational nurse specifically assigned to the resident or 
have had regular contact with the resident in the past month. No interviews will be held 
with the PwYOD themselves. Trained researchers and research assistants will collect the 
data through structured interviews with the nursing staff and from the resident’s medical 
files. The nurses from the participating SCUs will be aware that they are in the intervention 
condition, because that condition requires working with the care program. Therefore, it is 
not possible to blind the nurses, researchers or research assistants. No feedback will be  
given to the nurses during the assessments regarding the scores on the outcomes  
measures. 
Data Analysis
Data entry of the PwYOD and nursing staff outcomes will be performed in Project Manager 
Internet Server (ProMISe), a web-based data management system. All entered data will be 
checked to safeguard data entry. For the primary research question, the CMAI- score and 
the NPI-NH score will be used as outcomes. Age, sex, length of stay, dementia severity, and 
prescription of antipsychotics and other psychotropic drugs will be used as covariates.  
QoL (Qualidem), burnout (UBOS), job satisfaction (LQWQ), and job demands (LQWQ) scores 
will be used as secondary outcomes. Nurses age, sex, years of working experience, 
educational level, and the nurse-resident ratio will be used as covariates. The primary and 
secondary outcomes will be analyzed using multilevel linear regression and multilevel 
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logistic regression analyses. These analyses will calculate the effects of the care program 
on NPS, QoL, the prescription rate of psychotropic drugs, and the workload and job  
satisfaction of nursing staff. 
Process evaluation
A process evaluation will be carried out during the study, using the framework of first- and 
second-order process data as described by Leontjevas et al.(2012) [53]. First-order process 
data will be used for interpretation of the effect of the care program. This entails sampling 
quality (external validity) and intervention quality (internal validity). Sampling quality will 
be determined by (1) the recruitment and randomization procedure for the SCU, (2) the 
recruitment procedure of the PwYOD, and (3) the reach of the intervention (the proportion 
of SCU care staff participating in the care program). Intervention quality will be determined 
by (1) the relevance and feasibility of the care program and (2) the extent to which the  
program was performed. Second-order data will contain information about the delivered 
and received implementation components and the barriers and facilitators of the  
implementation process. These data will be evaluated using structured questionnaires  
and interviews with primary nurses, team leaders, psychologists and elderly care  
physicians.
Economic evaluation
A cost-consequences approach (CCA) will be used to estimate the monetary value of the 
care program. This method provides the most comprehensive presentation of information  
describing the value of an intervention and is also conceptually the simplest [54].  
The impact of the care program on resource use, costs and health outcomes will be  
estimated on the SCU and resident levels using a balance-sheet approach. Costs will  
include the following direct costs: (1) costs on the SCU level (time allocated for 
implementation of the care program); (2) cost of care per resident; and (3) PDU costs.  
Costs will also include indirect costs associated with staff absenteeism. The time needed 
for the educational program will be registered separately. Effects of the care program will 
include: agitation and aggression (assessed with the CMAI), QoL (assessed with the 
Qualidem), PDU of the PwYOD, and occupational disruptiveness of NPS for the nursing 
staff. 
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Discussion
The current paper describes the study design of an interventional study that addresses the 
management of NPS in YOD, known as the Beyond-II study. To our knowledge, this is the 
first study that addresses the management of NPS in institutionalized PwYOD. The focus of 
this study is on the (process) evaluation of the effectiveness and the costs and consequences 
of the implementation of a newly developed multi-component care program on the  
management of NPS in institutionalized PwYOD. We expect that the implementation of the 
care program will result in decreases in NPS and PDU. Implementation is also expected to 
result in higher job satisfaction among nursing staff.  
This study will contribute to the knowledge of the management of NPS in YOD, 
the mechanisms involved in the management of NPS, and implementation knowledge of 
care programs in nursing homes. A stepped wedge design will be used in this study to  
ensure that all participating YOD SCUs can benefit from the care program. Despite the 
many positive aspects of this study, there are some limitations that have to be considered. 
Selection bias could be a factor in our study. Although our participating YOD SCUs are 
recruited from all geographical regions of the Netherlands and are likely to represent the 
Dutch YOD nursing home population, selection bias may occur because all participating 
nursing homes are affiliated with the Dutch YOD Knowledge Center. This may be a different 
group than the YOD nursing homes that are not affiliated with the Dutch YOD Knowledge 
Center. Another limitation is that informed consent will be obtained for all PwYOD and it is 
possible that the group for which consent is obtained will be different from the group for 
which consent cannot be obtained. 
Despite these limitations, the stepped wedge design and assessment measures 
seem appropriate for this study and outweigh the few limitations. The described care  
program offers the YOD-SCU staff tools for the management of NPS in YOD. 
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Abstract
Background: An intervention for the management of neuropsychiatric symptoms in  
institutionalized people with young-onset dementia was implemented in care units  
delivering specialized treatment and support for younger people with dementia. 
Objectives: Data about sample quality and intervention quality was evaluated in order  
to better understand internal and external validity. In addition, data about the  
implementation strategy and factors affecting implementation were evaluated to improve 
further implementation of the intervention. 
Setting: Dutch long-term care facilities providing specialized care for young-onset  
dementia.
Measurements: A description of the recruitment, randomization procedure, and 
intervention reach was carried out in order to determine sample quality. To determine 
intervention quality data on satisfaction, relevance, feasibility, and fidelity was collected 
through a questionnaire and reports logged on the server of the web-based intervention. 
A description of the implementation strategy was provided. Barriers and facilitators for 
implementation were collected by a questionnaire and analyzed by deductive content 
analysis.
Results: Care units varied in size and were recruited from different geographical regions in 
the Netherlands. The informed consent rate of the residents was 87.7%. The majority of the 
nursing home staff was satisfied with the intervention. However, parts of the intervention 
were perceived as less relevant for the own organization. The feasibility of the intervention 
was considered low. The fidelity differed between care units. The implementation strategy 
did not overcome all barriers. Factors effecting implementation covered three themes: 
organizational aspects, culture of the organization, and aspects of the intervention. 
Conclusions: In general, our results showed sufficient internal and external validity  
warranting further effect analyses. Adaptations to specific steps of the care program 
should be considered to increase feasibility and sustainability. In addition, integration of 
the care program into the electronic health records is expected to further improve  
implementation.
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Introduction
In institutionalized people with young-onset dementia (YOD), neuropsychiatric symptoms 
(NPS) are highly prevalent [1,2]. NPS have been associated with negative health outcomes 
like a loss of quality of life, increased cost of care, and a high workload for nursing home (NH) 
staff [3-5]. Psychotropic drugs are often used in the treatment of NPS in institutionalized  
people with YOD [1], which are negatively associated with quality of life in both YOD and 
LOD [3,6-8]. Therefore, in the Behavior and Evolution of Young-ONset Dementia part 2  
(Beyond-II) study, an intervention for the management of NPS in YOD was implemented on 
long-term care units offering specialized treatment and support in YOD [9]. 
A randomized controlled trial (RCT) was conducted to evaluate the effect of the 
intervention on the prevalence of NPS and psychotropic drug use (PDU) in NH residents 
with YOD, and workload, absenteeism, and job satisfaction of the NH staff [9]. In order to 
interpret the outcomes of the RCT, information about internal and external validity is  
important [10]. Internal validity refers to the extent to which effects are a result of the  
intervention [11]. For example, a RCT could fail to find an effect of a potential successful  
intervention due to too small sample sizes [11]. External validity refers to the generalizability 
of the effects of the intervention [11]. For instance, if recruitment rates are low, the  
research population might not be representative of a wider population. 
Besides information on validity, a better understanding of the implementation 
process is necessary to understand why the intervention was or was not effective and how 
to improve sustainability in clinical practice [10, 12, 13]. A recent editorial stated that due 
to consequences of practical difficulties in conducting applied research in the context of 
daily practice, it is naïve to expect that complex intervention in NHs are always completely 
carried out as planned [14]. Therefore, potential successful interventions might fail to show 
effect, because they were not delivered as indented [12, 15-17]. This is expressed as low  
treatment fidelity [12,17]. In order to allow for conclusions about the effectiveness of the 
intervention in clinical practice, it is important to understand the relationship between 
contextual factors and the effectiveness of the intervention, rather than trying to control 
for contextual influences [13, 16]. This context consists of all factors, external to the  
intervention, which might facilitate or hinder implementation [17]. Previous implementation  
studies in NHs already reported on contextual barriers for implementation like staff  
turnover, staff shortage, low staff motivation, lack of leadership, absence of management 
support, and organizational changes [18-20]. In order to try to overcome these contextual 
barriers and increase effectiveness of our intervention, an implementation strategy was 
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developed alongside the intervention. Reporting on the used implementation strategy and 
how it was received is important as it provide future users of the intervention with vital 
information about how to reproduce the intervention [10, 17, 21]. 
A process evaluation provides knowledge on validity and implementation [10]. 
Therefore, in this study, a process evaluation was performed for an intervention aimed at 
improvement of the management of NPS in institutionalized people with YOD (1) to establish 
internal and external validity, and (2) to provide information about the implementation 
strategy and factors affecting implementation.  
Methods
This process evaluation is part of the Beyond-II study and was conducted before effect 
analysis of the intervention. The design of the Beyond-II study and information about the 
development of the intervention are described in full detail elsewhere [9, 22].
Intervention
The intervention in this study is based on the “Grip on challenging behavior” care program 
[22, 23]. After implementation of this care program in late-onset dementia (LOD), a  
decrease in NPS and PDU, and an increase in job satisfaction of the NH staff was found [24, 
25]. The care program provided guidance for the multidisciplinary team involved in the 
management of NPS in Dutch NHs (nursing staff, specially trained elderly care physicians 
and psychologists) [26, 27]  to structure the process of detection, analysis, treatment, and 
evaluation of NPS (Figure 1). NPS could be every form of behavior that is perceived as  
challenging by the NH resident or by people surrounding the residents (like NH staff,  
relatives, other residents), encompassing various symptoms including affective symptoms, 
such as depression, anxiety and apathy, and behavioral symptoms like aggression, agitation,  
disinhibition, delusions, and hallucinations. 
The steps of the care program were consecutive and formed a cycle, except for 
the evaluation of appropriateness of psychotropic drug prescription which was a separate 
step (Figure 1). The first step of the care program was detection of NPS. This occurred 
through usual observations of the multidisciplinary team or with the use of a screening tool 
every six months by a vocational nurse. The screening tool was based on the Neuropsychiatric 
Inventory–Questionnaire (NPI-Q) [28]. After NPS were detected, a structured analysis of the 
NPS was conducted by the vocational nurse. The analysis contained questions regarding 
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the time and place of occurrence of the NPS, possible causes, and actions already  
undertaken by the care staff. In addition, a tool for the detection of unmet needs possibly 
underling the NPS was used by the vocational nurse. The tool was adapted and extended 
based on the Dutch version of the Camberwell Assessment of Need for the Elderly (CANE) 
[29, 30]. When necessary, the physician and/or the psychologist continued the analysis. 
Their analyses consisted of a checklist to rule out physical or psychiatric causes (physician) 
or a functional analysis of the NPS (psychologist). After the analysis of the clinician,  
treatment options were discussed within the multidisciplinary team and a treatment plan 
was established by a clinician (psychologist or physician). The treatment plan contained a 
specifically defined, measurable treatment goal. The care program did not prescribe a  
specific intervention. The choice of the intervention relied on the hypothesized causes of 
the NPS, the preferences of the resident, and the available options in the NH. However,  
in accordance with the guidelines on the management of NPS [31-33], psychosocial  
treatments were preferred; PDU only if other treatment had little or no effect. Treatment 
outcomes were evaluated by the multidisciplinary team. The frequency and severity of NPS 
before and after treatment were compared and if unsatisfactory, other treatments were 
considered or the analysis was performed again. 
In a separate step of the care program, the physician used a tool for the  
evaluation of appropriateness of psychotropic drug prescription within the first two 
months after implementation for all residents (with our without NPS). The tool was  
adapted and extended based on the Appropriateness of Psychotropic Drug Prescription In 
Dementia (APID)-instrument [34, 35]. After this initial screening, the tool was used at the 
physician’s own discretion. 
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Figure 1. The five steps of the care program ‘Grip on NPS in institutionalized people 
with YOD [9]. 
Reprinted with permission
NPS = Neuropsychiatric Symptoms; YOD = young-onset dementia; PD’s = Psychotropic Drugs.
Process evaluation model
Previous NH intervention studies successfully used a model proposed by Leontjevas and 
colleagues, following the framework of Linnan and Steckler [10, 18, 36]. In line with this 
model, first-order process evaluation data consisting of sample quality and intervention 
quality is evaluated in order to better understand internal and external validity. In addition 
second-order process evaluation data consisting of knowledge on the implementation 
strategy and factors affecting implementation is evaluated to improve further  
implementation [10].
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First-order process evaluation
To evaluate sample quality a description was provided of (1) the recruitment and  
randomization of the YOD SCUs, and (2) the recruitment and informed consent procedure 
of the NH residents. Also, intervention reach was described by (3) a description of the  
proportion of residents participating in the study in relation to the number of residents 
eligible for inclusion, and (4) the proportion of staff involved in the use of the care program.
Intervention quality was determined by (1) the satisfaction with and relevance of 
the care program, (2) the feasibility of the care program, and (3) fidelity of the intervention. 
The satisfaction with and relevance of the care program were investigated at the end of the 
study with a questionnaire, which was distributed among vocational nurses, physicians, 
and psychologists. Participants were asked if they would recommend the care program to 
other colleagues (answer categories: yes, no, unknown). Additionally, for each step of the 
care program (Figure 1) they were asked if they perceived it as relevant steps in the  
management of NPS (answer categories: yes, no, unknown). 
In order to investigate feasibility, participants were asked if they were able to 
perform the care program in the current available time on a questionnaire (answer categories: 
yes, no). Fidelity of the intervention was evaluated by establishing the proportion of the 
multidisciplinary team participating in an educational program (which was part of the  
implementation strategy). In addition, the extent to which the care program was  
performed for each NH was logged on the server of the web-based environment providing 
data on the number of identified residents with NPS and data on how often each step of 
the care program was completed.
Second-order process evaluation
A detailed description of the implementation strategy used alongside the intervention was 
provided. Furthermore, barriers and facilitators for the implementation of the intervention 
were inventorized through open ended questions on a questionnaire. 
Data collection procedure
Quantitative data were analyzed with the Statistical Package for the Social Sciences (SPSS)  
version 22 by calculating descriptive data (frequencies, percentages, and standard deviations). In 
order to analyze the qualitative data, a deductive content analysis was performed [37]. The first 
author (B.A) developed a structured analysis matrix based on the implementation knowledge 
of the original care program developed in the ‘Grip on challenging behavior’ study [18, 22]. This 
study identified three themes of implementation knowledge: organizational aspects, culture of 
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the organization, and aspects of the intervention. Two authors (J.D. and B.A.) coded the data for 
correspondence with the themes separately. Disagreements were solved by discussion. 
 
Results
First-order process evaluation
Recruitment and randomization of young-onset dementia special care units
YOD special care units (SCUs) were recruited through NHs that are affiliated with the Dutch YOD 
Knowledge Center (DKC). Twenty-five NHs were approached of which 15 decided to participate. 
Two YOD SCUs were excluded because they were considered to small (less than 12 residents). 
Reasons for refusing to participate were planned reorganizations and participation in other 
research projects. The thirteen SCUs which participated varied in size at time of inclusion  
(Mean = 25.9 residents, SD = 11.9). The SCUs were located in different geographical regions of 
the Netherlands of which five in the densely populated western part of the Netherlands.
Recruitment and informed consent procedure of the NH residents
The inclusion and exclusion criteria [9] were provided to staff of the participating YOD SCUs for 
the initial selection of residents eligible for the study. The NH staff provided the legal  
representatives of the residents who probably met inclusion criteria with informed consent (IC) 
forms and folders with information about the study. The SCU implemented the intervention on an 
unit level. Therefore, all legal representatives were informed that also residents without IC would 
be exposed to the intervention. To respect privacy, no data on demographic characteristics and 
the presence of NPS was collected by researchers from residents of which IC was not provided. 
During the study, deceased residents could be replaced by newly admitted residents. 
Residents’ reach
Before the first assessment, IC was provided for 213 (87.7%) residents. In eleven SCUs IC was 
provided for more than 87.0% of the residents and in two SCUs approximately 60.0% of the  
legal representatives did provide IC (Figure 2). At each of the four assessments, approximately 15 
percent  of the participating residents had moved to another unit or had deceased. Of the newly 
admitted residents, only few legal representatives did not provide IC. Although IC was often  
provided for newly admitted residents, there was a small decline in the number of residents 
participating in the study (Figure 2). This decline was due to a decrease in size of the SCUs. Two 
SCUs closed beds due to organizational changes.
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TO
T1
T2
T3
Deceased:  12
Moved: 6
Newly admitted:  19
4 SCUs (80 residents)
crossed over to
intervention
Deceased:  10
Moved:  3
Newly admitted:  15
4 SCUs (56 residents)
crossed over to
intervention
Deceased:  18
Moved:  8
Newly admitted:  27
5 SCUs (68 residents)
crossed over to
intervention
Deceased:  16
Moved:  10
Newly admitted:  9
Deceased:  7
Moved:  4
Newly admitted:  6
13 YOD SCUs
Eligible for inclusion:   243
No informed consent:  30
Deceased before T0:   3
Total:   210
INTERVENTION 4 SCUs
Eligible for inclusion:  82
No informed consent:  2
Total:  80
CONTROL 9 SCUs
Eligible for inclusion:  131
No informed consent:  2
Total:  129
INTERVENTION 8 SCUs
Eligible for inclusion:  137
No informed consent:  1
Total:  136
CONTROL 5 SCUs
Eligible for inclusion:  68
No informed consent:  0
Total:  68
INTERVENTION 13 SCUs
Eligible for inclusion:  187
No informed consent:  0
Total:  187
Figure 2. Results of recruitment of the residents of the Beyond-II study.
YOD SCU = Young onset dementia special care unit
There were four, half yearly, assessments: T0, T1, T2, T3. 
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Nursing home staff reach
In total, 323 nurses, 16 psychologists, 16 physicians, and 9 team leaders were involved in 
the use of the care program at time of the first assessment. Of these, 23.8% (N = 77) of the 
nursing staff, 25.0% (N = 4) of the psychologists, 25.0% (N = 4) of the physicians, and 44.4% 
(N=4) of the team leaders were not working on the SCU anymore at the last assessment. 
Main reasons were organizational changes, transfer to another unit or other health care 
organization, retirement, or maternity leave. For all physicians and psychologists who left 
during implementation, new clinicians were employed. They received information and 
instruction about the care program from colleagues or from one of the researchers. Four 
team leaders left due to organizational changes and were not replaced. 
The satisfaction with and relevance of the care program
At time of the last assessment, eighty-two NH staff members (74.6%) responded on a  
web-based questionnaire. Fifty-eight percent (N = 35) of the respondents was satisfied with 
the overall content of the care program, and 55.0% (N = 33) would recommend the care 
program to other colleagues. The step analysis by the nursing staff was perceived as the 
most relevant in the management of NPS (perceived as relevant by 43.9%, N = 29)  
(Table 1.). After the analysis by the nursing staff, the step evaluation was perceived as most 
relevant in the treatment of NPS (perceived as relevant by 42.1%, N = 8). The critical  
appraisal of the appropriateness of PDU was most often perceived as irrelevant (83.3%, N = 5).
Feasibility of the care program
With regard to the feasibility of the care program, most respondents (61.9%, N = 39) stated 
that it was not feasible to use the care program in the time available to them in day to day 
practice. Especially the steps ‘analysis by the nursing staff’ and the ‘detection of unmet 
needs’ were rated as too time consuming.  
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Table 1. Perceived relevance of each step of the care program by nursing home staff members. 
Relevant Irrelevant Not able to rate
Detection 27.50 % (N = 19) 49.30% (N = 34) 23.2% (N = 16)
Analysis nurses 43.90% (N = 29) 30.30% (N = 20) 25.80% (N = 17)
Needs assessment a 34.50% (N = 20) 19.00% (N = 11) 46.60% (N = 27)
Involving family in 
needs assessment
29.50% (N = 13) 13.60% (N = 6) 56.80% (N = 15)
Analysis clinician b 37.50% (N = 9) 37.50% (N = 9) 25.00% (N = 6)
Treatment b 31.80% (N = 7) 36.40% (N = 8) 31.80 (N = 7)
Evaluation b 42.10% (N = 8) 26.30% (N = 5) 31.60% (N = 6)
PDU assessment c 16.70% (N = 1) 83.30% (N = 5) -
a Part of analysis nurses; 
b Only rated by psychologists and physicians; 
c Only rated by physicians. 
22.7% (N=25) of the questionnaires were incomplete. Questions that were available were 
also included in the analysis. 
 
Fidelity of the intervention
Of the nursing staff, 48.0% (N = 155, SD = 24.3) participated in the educational program (part of 
the implementation strategy). In three SCUs 76.0-95.0% participated, in six 32.0-54.0%
participated, and in four SCUs 17.0-26.0% participated. With regard to the clinicians, 50.0% (N 
= 8) of the psychologists and 43.8% (N = 7) of the physicians participated in the educational 
program. Of the nine SCUs that employed a team leader, all but one team leader (88.9%, N = 8) 
participated in both training sessions. The main reasons for both the nursing staff and the 
clinicians not participating were being on leave or ill.Server logs of the care program showed 
that the care program was used for 368 residents (range per SCU = 6-66 residents). Although we 
only collected data from residents who met inclusion criteria and for whom IC was provided, 
the anonymous server logs also contain residents not participating in the study. This might 
result in an overestimation of fidelity. Furthermore, after detection and analysis, the NH staff 
may conclude there are no signs of NPS (Figure 1). Therefore, the number of times the steps 
‘treatment’ and ‘evaluation’ are completed will be lower compared to the other steps. The step 
of the detection of NPS was performed most often (completed 415 times). The step of the
construction of a treatment plan was used the least (completed 41 times), followed by the PDU 
assessment (completed 45 times) (Table 2). Fidelity differed between SCU’s. One SCU did only 
perform the step detection twice. The assessment of PDU was not (or only once) used by nine 
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SCU’s. Six SCU’s did not (or only once) use the later steps of the care program: treatment and 
evaluation.
Table 2. The extent to which each step of the care program was performed.
Unit sizea  
(residents)
Groupb Residents 
in care 
programc
PDU  
assess-
mentd
Detection Analysis  
nurses
(after  
screening 
tool)e
Analysis  
clinician
Treatment 
f
Evaluation 
f
YOD SCU  
number
1 36 1 49 1 95 56 (42) 43 6 6
2 48 1 66 1 129 106 (85) 99 11 17
3 32 1 32 0 42 29 (24) 14 2 2
4 18 1 22 11 33 36 (26) 22 1 1
5 14 2 16 0 11 7 (3) 5 0 0
6 14 2 13 12 16 9 (4) 8 2 2
7 18 2 22 0 2 14 (2) 21 10 14
8 45 2 37 0 9 10 (7) 10 0 0
9 22 3 39 12 16 18 (10) 18 5 3
10 21 3 6 0 6 5 (5) 7 0 0
11 20 3 20 8 19 13 (11) 9 1 1
12 35 3 39 0 28 18 (15) 11 3 7
13 14 3 7 0 9 8 (7) 11 0 0
a At time of inclusion (T0).
b Period of working with care program Group 1: 18 months, Group 2: 12 months, Group 3: 6 months. 
c Including residents who moved, deceased, and newly admitted residents during  
implementation, and residents residing on the care unit who did not participate in the study. 
Therefore, for a SCU the unit size can be smaller than the number of residents in the care program.
d Times each step of the care program was completed.
e Times that the analysis was followed after the screening tool for the detection of NPS  
revealed symptoms of NPS. The remaining times followed after the detection of NPS in 
daily observations (without the use of the screening tool).  
f Step is only completed if step analysis nurses reveals NPS and clinician perceives treatment  
as necessary. Therefore, these steps will be less often completed compared to the other step.
YOD SCU = young onset dementia special care unit. 
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Second-order process evaluation
Implementation strategy
A multi-component implementation strategy was used to increase acceptability (the  
perception that the care program is satisfactory) and adoption (the intention to use) of the 
NH staff and increase feasibility, fidelity, and sustainability (the extent to which the care 
program will be maintained) of the intervention [12, 21]. The strategy was based on  
perceived barriers in implementation of the original care program in LOD [18]. 
In order to increase acceptability and adoption, at the start of the implementation 
the NH staff received an educational program that consisted of two training sessions (of 2.5 
hours and 1.5 hours respectively). In the educational program, the causes and mechanisms 
of NPS were explained and the need for a specific intervention in YOD was discussed.  
In addition, instruction in the use of the care program was provided. This educational  
program was given by one of the authors (J.D. or B. A.). In order to increase fidelity and  
sustainability, six months after implementation, all NH staff received an additional training 
(of 1.5 hours). In this training session, facilitators and barriers for implementation of the 
care program in the own organization were discussed and the NH staff was stimulated to 
think about how to address these barriers and therewith facilitate further implementation.
In order to increase acceptability, fidelity, and sustainability a champion  
supporting the implementation of the care program was appointed in all participating YOD 
SCUs. The NH staff working on the YOD SCUs decided on who would become champion  
using the following selection criteria: has to be a user of the care program or closely  
involved (e.g. team leader), has to have leadership in the multidisciplinary team (e.g.  
vocational nurse, physician, psychologist, or team leader), has to be easy to approach, has 
to be supporting of the care program, and has to be capable of motivating the team.  
Together with this champion, possible barriers and facilitators for successful implementa-
tion were explored using a questionnaire before and every six months during the imple-
mentation of the intervention. If possible, the barriers were addressed and facilitators were 
used to further enhance implementation in that particular SCU. 
In the original care program, providing the care program on paper forms was 
perceived as a barrier for implementation since this did not attune with the current  
working methods and electronic health records [18]. Therefore, in order to increase  
feasibility, the current care program was offered in a web-based format. 
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Factors affecting implementation
Data on barriers and facilitators for implementation were organized into the three major 
themes identified in previous implementation research [18, 22]: organizational aspects, 
culture of the organization, and aspects of the intervention (Table 3). 
Organizational aspects
Barriers from an organizational perspective were high rates of temporary staff or low  
educated staff and organisational changes (e.g.  renovations or transitions towards  
self-directed teams). In addition, high rates of staff turnover was perceived as a barrier, as 
new staff members were not always well informed about the care program and needed 
time to get acquainted with the use. 
An organizational facilitator was limited involvement in new research projects 
during the implementation of the care program that could interfere with carrying out the 
care program. In addition, regular multidisciplinary meetings were perceived as a facilitator. 
Several SCUs, in which the disciplines did not meet each other regularly, started with  
multidisciplinary meetings (at least once every two weeks) before implementation of the 
care program.
 
- ‘’Being made aware that involvement in new research projects could interfere with 
implementation, made it easier to reject requests for participation of the care unit 
in other important projects’’.[P7] 
Culture of the organization
A barrier related to the culture of the organisation was lack of involvement of the  
multidisciplinary team in the educational program. Involvement in the educational program 
increased commitment and motivation in the use of the care program. However, not all NH 
staff participated. 
A cultural facilitator was the openness to changing working routines. The NH 
staff often mentioned that they found it necessary that a care program for the management 
of NPS would be implemented on their care unit and were confident that the care program 
would diminish NPS, which made them more eager to invest time in implementation.  
In addition, the support of the champion and support of the management were often  
mentioned as facilitators for implementation.
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- ’Implementation is time consuming and sometimes frustrating. To be honest,  
we are still not there yet. However, I believe our residents will benefit from this 
intervention and therefore we will continue with implementation’’. [A12]   
 
Aspects of the intervention
Respondents mentionded overlap with curent working methods, especially with tools 
already available in the electronic health record. Because it was mandatory to report infor-
mation on the management of NPS in the electronic health record, the NH staff was more 
inclined to continue to work according to their old working routine. No facilitators were 
revealed within this theme. 
- ‘’We did not let go our own working methods during implementation. In addition 
to the forms of the digital care program, it was mandatory to still use our own 
forms in the electronic health record. In my experience this doubled the work’’. [Z5]
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Discussion
First-order proces data on validity showed that the participating SCUs varied in size and 
location. The informed consent rate of the residents was 87.7%. Most NH staff members were 
satisfied with the overall content of the care program. However, parts of the intervention 
were perceived as less relevant for the own organization. The feasibility of the intervention 
was considered low. The fidelity differed between steps of the care program and SCUs.  
Second order process data on implementation showed that staff turnover and shortage,  
organizational changes, lack of involvement in educational program, and overlap with  
current working methods were barriers for implementation. Facilitators for implementation 
were multidisciplinary collaboration, limited involvement in other projects, openness to 
change in working procedures, and support of the ambassador and management.
First-order process evaluation
The variety in size of the SCUs and the location of the SCUs in different geographical  
regions of the Netherlands, the high proportion of residents with IC, and the sufficient sample 
size allow for effect analyses and generalization of the study effects. 
The differences in perceived relevance and low feasibility of steps of the care program 
can negatively influence the applicability of the intervention and therewith hinder external  
validity. Adaptations to increase relevance and feasibility of some steps of the care program 
should be considered. The analysis by the nursing staff was most often rated as too time  
consuming and the need assessment in this analysis was not perceived relevant for all residents 
(i.e. in advanced dementia or for residents who had been residing on the SCU for a long period). 
In order to increase the relevance and feasibility, the need assessment could be changed into 
an optional step in the care program reserved for newly admitted residents or residents which 
needs are still unclear according to the vocational nurse. However, one should be aware that an 
extensive (and therewith possibly time consuming) analysis of the behavior is a precondition to 
indentify the underlying cause. Therefore, special attention needs to be directed to strategies to 
further increase adoption of the care program by the NH staff. 
Fidelity of the intervention was not optimal. The low participation rates in the 
educational program in some SCUs and the differences in degree of implementation between 
steps of the care program, will likely reduce the effectiveness of the intervention and  
therewith decrease internal validity. To investigate possible differences in effects due to 
low treatment fidelity in some SCUs, subgroup analysis including participation rate and 
care program performance should be part of the effect analyses. 
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Second-order process evaluation
Despite the use of an implementation strategy which was successful in addressing some of 
the barriers already known from previous research, the implementation of the care program 
was not optimal. Some barriers known in advance, like staff turnover, staff shortage, and 
organizational changes, are part of daily practice and could not be resolved [18-22]. 
 In addition, steps of the program did not add to the working methods from the 
perspective of the NH staff. For instance, in some SCUs a screening tool for NPS was already 
available in the electronic health record. In order to create commitment to change the old 
working routine, the staff needs to believe in the benefits of the intervention for the own 
organization [27]. Therefore, we believe that perceived irrelevance of some steps of the 
care program hindered implementation. In future implementation, more attention needs 
to be paid to the appropriateness (the compatibility of the intervention for the given  
setting) for the own organisation [12]. Integration of the care program in the electronic 
health record could prevent overlap with current working methods. In addition, relevance 
of the intervention might increase if it is tailored to the specific working method of a  
specific SCU, rather than completely standardized [38]. 
In order to increase fidelity by improving the participation rate of the NH staff in 
future implementation studies, changing the structure of the educational program could 
be considered. NH staff usually works according to a schedule. Enabling the NH staff to 
follow training in the intervention at different times and/or several days, will likely create 
the opportunity for more NH staff members to participate [39]. This would also allow staff 
members who are on leave or ill, the main reasons for not participating in our educational 
program, to participate. 
Furthermore, although assigning champions indeed facilitated implementation, 
the dependency on one champion might make implementation vulnerable. Should the 
designated champion be less competent or depart, this would negatively impact sustainability. 
For future implementation, it could be helpful to share the responsibilities of the champion 
among several staff members.   
At last, in future implementation studies the readiness for change needs to be 
taken into account in order to increase adoption [40]. For example, in our study, the high 
prevalence rates of PDU in YOD and the high rates of inappropriate psychotropic drugs 
prescription found in dementia stresses the need for a tool for the evaluation of  
appropriateness of psychotropic drug prescription [1, 2, 41]. However, almost all  
physicians in our study perceived the tool as irrelevant, suggesting that they did not  
perceive changes were needed: hindering adoption. In order to increase the readiness to 
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change, more education specifically for the elderly care physicians about the importance 
of the tool before implementation could have been helpful [42]. Another solution might be 
to integrate the tool in the step ‘detection’, instead of using it as a separate step in the care 
program which could be used at the users’ own discretion. Consequently, the physicians 
would need to use the tool systematically every six months for all residents. By using the 
tool, they might perceive its benefit and therewith become more accepting. However, we 
should be aware that forcing the use of the tool could also create resistance and therewith 
hinder implementation [42]. 
 
Conclusions
First-order proces data revealed that the SCUs varieted in size and location, the sample 
sizes were large enough to establish clinical relevant effects, and most respondents were 
satisfied with the overall content of the intervention. Therefore, sample and intervention 
quality allow for effect analyses. 
With regard to the second-order process data, the implementation strategy was 
successful in addressing some of the barriers already known from previous research.  
However, it was impossible to control for all contextual influences. Still, we expect that 
creating awareness of these inevitable barriers before implementation, will somewhat 
have diminished their negative influence on the implementation process. Adaptations to 
specific steps of the care program should be considered to increase feasibility and 
relevance. We expect that integration of the care program in the electronic health records 
will further improve implementation. Also, tailoring the care program to the specific  
working method of each SCU should be considered. For future implementation studies, it 
is important to include strategies that take into account the readiness to change of the NH 
staff and increase commitment.
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Abstract
Objectives: An intervention that has shown effectiveness in the management of  
neuropsychiatric symptoms (NPS) in institutionalized people with dementia was  
specifically tailored for the use in institutionalized people with young-onset dementia 
(YOD). The effect of the intervention on the presence of NPS, particularly agitation and 
aggression, and psychotropic drug use (PDU) in YOD was evaluated. 
Design/ Setting: A randomized controlled trial was conducted using a stepped wedge 
design. Thirteen YOD special care units were randomly assigned to three groups, which 
received the intervention at different time points. Four assessments took place every six 
months during a period of eighteen months. 
Participants: Two hundred and seventy-four people with YOD  residing on YOD special care 
units participated, of whom 131 in all assessments.
Intervention: The intervention consisted of an educational program combined with a care 
program, which structured the multidisciplinary process of managing NPS. The care  
program included the following five steps: the evaluation of psychotropic drug  
prescription, detection, analysis, treatment and evaluation of treatment of NPS.
Measurements: The Cohen-Mansfield Agitation Inventory and the Neuropsychiatric  
Inventory, nursing home version were used to assess NPS. Data on PDU was retrieved from 
residents’ medical files. Multilevel models were used to evaluate the effect of the  
intervention, which accounted for clustering of measurements within clients, within units.
Results: No significant differences on agitation and aggression, other NPS, and PDU after 
crossing over to the intervention condition were found. 
Conclusions: The intervention for the management of NPS in nursing home residents with 
YOD was not more effective in reducing agitation and aggression, other NPS, or PDU  
compared to care as usual.
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Introduction
Young-onset dementia (YOD) is defined as dementia with symptom onset before the age of 
65. In nursing home (NH) residents with YOD, neuropsychiatric symptoms (NPS) are  
common [1]. NPS encompass various symptoms such as depression, anxiety, apathy,  
aggression, agitation, disinhibition, delusions, and hallucinations. Mulders et al. found in 
the Behavior and Evolution of Young ONset Dementia, part 1 (Beyond-I) study that 90% of 
NH residents with YOD showed one or more NPS [1][11]. These high rates are troublesome 
given the serious negative health outcomes associated with NPS in dementia, such as loss 
of quality of life of the NH resident, high workload for NH staff, and increased costs of care 
[2-5]. Agitated behaviors are highly prevalent in YOD. Especially agitated behaviors are 
strongly related to distress of professional caregivers and to reduced quality of life in both 
NH residents with late-onset dementia (LOD) and YOD [3-7]. Psychotropic drug use (PDU) is 
common in the management of NPS in NH residents with LOD and YOD [8, 9]. PDU is  
associated with poor health outcomes, such as stroke, increased mortality, and reduced 
quality of life [3, 10, 11]. Therefore, Dutch guidelines for the management of NPS in  
dementia recommend that pharmacological interventions should be temporary and only 
be used if psychosocial interventions have little or no effect [12-14]. However, still between 
76.9 - 87.6 % of the NH residents with YOD use one or more psychotropic drug(s) [4, 8]. 
Those rates seem higher compared to PDU in NH residents with LOD [8].
The high prevalence rates of NPS and PDU in YOD stresses the need for effective 
nonpharmacological interventions especially in the management of NPS in YOD.  
To successfully manage NPS, many models emphasize that the underlying causes of NPS 
need to be identified and treated [15]. One of these models is the unmet-needs framework, 
in which NPS are perceived as behaviors through which the person with dementia might  
indirectly communicate an underlying need [15]. Needs can be medical (e.g. physical ill-
ness, pain, mobility), psychosocial (e.g. life habits, premorbid personality), or  
environmental (e.g. under/over stimulation, behavior of  NH staff/ other residents) [16, 17]. 
With knowledge of the underlying causes of NPS, an intervention can be individualized 
to the specific needs of the residents, instead of suppressing the behavior with the use of 
psychotropic drugs, concealing behavior through which the person with dementia might 
indirectly communicate an underlying need [16, 18, 19]. People with YOD have specific 
age-related care needs regarding daytime activities, social interaction, intimate relationships, 
and information [20]. These care needs are often unmet [20]. In community-dwelling peo-
ple with YOD these unmet care needs are strongly related to the presence of NPS [20]. It is 
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likely that the same relation between unmet care needs and NPS applies to NH residents 
with YOD. Therefore, in order to decrease the high rates of NPS in NH residents with YOD, 
these specific needs should be addressed.
In the Netherlands, a multidisciplinary team including nursing staff, elderly care 
physicians and psychologists is involved in the management of NPS in NHs [21, 22]. In the 
current study, an intervention which provides guidance for these disciplines to properly 
work together to identify and to treat the underlying causes of NPS in YOD specifically 
was developed. The intervention was based on The “Grip on challenging behavior” care 
program that has shown effectiveness in the management of NPS in LOD [23-26]. In order 
to address the high levels of unmet care needs and high prevalence rates of PDU in YOD, a 
tool for the detection of unmet needs [27] and a tool for the evaluation of appropriateness 
of psychotropic drug prescription [28]) were added to the original intervention [29]. 
The aims of the study are to (1) evaluate the effect of the intervention on the  
prevalence of NPS, particularly agitation and aggression, compared to care as usual, and 
(2) evaluate the effect of the intervention on PDU. 
Methods
This cluster randomized controlled trial (RCT) is part of the Behavior and Evolution of 
Young-ONset Dementia, part 2 (Beyond-II) study. The full study protocol has been published 
elsewhere [29]. In a previous study, process data was assessed in order to be able to  
interpret the outcomes of this RCT [30]. In general, the process data showed sufficient  
internal (the extent to which effects are a result of the intervention) and external (the  
generalizability of the effects of the intervention) validity allowing for further effect  
analyses [30, 31]. 
Setting and subjects
Recruitment procedures and reach of the YOD special care units (SCUs) and NH residents 
are described in more detail elsewhere [30]. In short, in this study thirteen YOD SCUs  
participated, which are care units delivering specialized treatment and support for people 
with YOD. The YOD-SCUs were recruited through NHs that are affiliated with the Dutch 
YOD Knowledge Center (DKC). Residents with a dementia diagnosis with a symptom onset 
before the age of 65 who resided on the YOD SCU for at least one month were eligible for 
inclusion in the study. The exclusion criteria were lack of informed consent provided by the 
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legal representative, dementia caused by human immunodeficiency virus (HIV), traumatic 
brain injury, Down’s syndrome, Korsakov syndrome or Huntington’s disease. Diagnoses of 
dementia subtype were made before inclusion, according to internationally accepted  
criteria for diagnosing dementia subtypes and were retrieved from medical files [32-37]. 
Newly admitted residents were recruited until the end of the study, replacing deceased 
residents and residents who moved to another care unit during the study. 
Intervention
The development of the intervention ‘Grip on NPS in institutionalized people with YOD’ is 
described in detail elsewhere [29]. The intervention consisted of an educational program 
and a web-based care program. The educational program involved two training sessions 
(of 2.5 and 1.5 hours respectively) in which causes and mechanisms of NPS were discussed 
with the NH staff and the use of the care program was explained. After receiving the 
educational program, the care program on the management of NPS was implemented 
(figure 1). This care program provided a structural multidisciplinary approach on the  
management of NPS, consisting of five steps. The first and separate step was a tool for the 
evaluation of appropriateness of psychotropic drug prescription by the elderly care  
physician. The tool was adapted and extended based on the Appropriateness of  
Psychotropic Drug Prescription In Dementia (APID)-instrument [28, 38, 39]. The tool was 
performed for all residents (with or without NPS) in the first two months after the SCU was 
enrolled in the intervention condition. After the initial screening, the tool was used at the 
physician’s own discretion. The other four consecutive steps of the care program had a 
circular structure (figure 1). Detection of NPS occurred through usual observations of the 
multidisciplinary team or with the systematic use of a screening tool every six months by 
a vocational nurse (or by a nurse who had regular contact with the resident in the past 
month). When NPS were detected, a structured analysis of possible causes of the NPS  
observed was conducted by the (vocational) nurse. This analysis included a tool for the 
detection of unmet needs possibly underling the NPS. The tool was adapted and extended 
based on the Dutch version of the Camberwell Assessment of Need for the Elderly (CANE) 
[27]. When necessary, the elderly care physician and/or the psychologist continued the 
analysis. After this analysis, treatment options were discussed within the multidisciplinary 
team and a treatment plan was established by the elderly care physician and/or the  
psychologist. The treatment outcomes were evaluated by the multidisciplinary team and if 
unsatisfactory, other treatments were considered or the analysis was performed again.  
All tools of the care program were fully digitalized and contained automatic reminders.
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Figure 1. The five steps of the care program ‘Grip on NPS in institutionalized people 
with YOD [29]. 
Reprinted with permission
NPS = Neuropsychiatric Symptoms; PD’s = Psychotropic Drugs. 
Design
To evaluate the effect of the intervention, a stepped wedge design was used (Table 1). This 
design allows clusters (in this study groups of YOD SCUs) to crossover from the control to 
the intervention condition over time, assuring that all YOD SCUs received the intervention 
[40]. The thirteen YOD SCUs were randomly assigned to three groups. Every six months a 
new group entered the intervention condition. The control condition consisted of care as 
usual without the educational program and use of the care program. Four assessments 
took place every six months during a period of eighteen months (September 2015 - April 
2017): before implementation (T0), during implementation (T1 and T2) and at the end of 
implementation (T3). 
Psychotropic 
drugs evaluation
The elderly care
physician  
evaluates all PD’s 
prescribed for NPS
Detection
Every six months 
the nursing staff  
screens all patients 
of the special care 
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spontaneously
No symptoms  
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of NPS
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Table 1. Stepped wedge design [29].
Group 1 Group 2 Group 3
T0 0 0 0
T1 1 0 0
T2 1 1 0
T3 1 1 1
Reprinted with permission 
0 = control condition; 1= intervention condition 
There are four, half yearly assessments. Each group consists of four or five YOD-SCU’S
Data collection and ethical considerations
The Beyond-II study protocol was approved by the Medical Ethics Committee region Arn-
hem/Nijmegen (file number 2015-1558) and registered in the Dutch Trial Register (Trial ID 
NTR5018). This research project was conducted according to the principles of the Declara-
tion of Helsinki (version November 2013, www.wma.net) and in agreement with the laws 
regarding medical-scientific research in humans (WMO). 
Written informed consent was obtained from the legal representative of each 
resident. After receiving informed consent, trained researchers and research assistants 
collected the data from the resident’s medical files and through structured interviews with 
nursing staff members who were most involved in the daily care of the residents. No feed-
back was given to the nursing staff members during the assessments regarding the scores 
on the outcomes measures.
Primary outcome
The Dutch version of the Cohen-Mansfield Agitation Inventory (CMAI-D) was used to 
assess agitation and aggression [16, 41]. The CMAI has a well-established validity and 
reliability and assesses 29 agitated or aggressive behaviors [41]. The frequency of each 
symptom is rated on a seven-point frequency scale (range 1-7) ranging from never to 
several times an hour. We used CMAI factors based on a previous study in LOD in which 
three CMAI factors in a large NH sample were found: physically non-aggressive behaviors 
(range 7-49), physically aggressive behaviors (range 8-56), and verbally agitated  
behaviors (range 4-28) [42]. 
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Secondary outcomes
To determine effects of the care program on other NPS, the Dutch version of the Neuropsychiatric  
Inventory-nursing home version (NPI-NH) was used. The NPI-NH has a high interrater  
reliability and is found to be a valid instrument for the assessment of a wide range of NPS 
in dementia [43, 44]. The NPI-NH consists of twelve NPS: delusions, hallucinations,  
agitation/aggression, depression, anxiety, euphoria, apathy/indifference, disinhibition, 
 irritability/lability, aberrant motor behavior, nighttime behavior disturbances, and  
appetite/eating disturbances. For each symptom a screening question is used to determine 
whether the symptom is present. If the symptom is present, Frequency (F) and Severity (S) 
are rated on a four-point (ranging from 1-4) and three-point Likert-scale (ranging from 1-3), 
for each symptom, respectively. Scores for each symptom are calculated as F x S (ranging 
from 1-12). A symptom score of at least 4 is considered clinically relevant [45, 46]. 
PDU was derived from the nursing homes pharmacists’ electronic files and was 
classified according to the Anatomical Therapeutic Chemical (ATC) classification system 
into antipsychotics, anxiolytics, hypnotics, antidepressants, anti-epileptics, anti-dementia 
drugs, and any psychotropic medication [47]. Pro re nata medication was not included 
because it was unclear if and how often these drugs were actually used. Furthermore,  
anti-epileptics used by residents with epilepsy were not registered as PDU.
Other measurements
Medical and demographic data were extracted from the resident’s medical files. Data on 
dementia subtype, age, gender, length of stay at the SCU, and date of inclusion were  
recorded. Dementia severity was assessed with the Global Deterioration rating Scale (GDS) 
[48]. The GDS describes seven different stages of dementia on a seven-point scale (1-7), 
ranging from “subjectively and objectively normal cognition” to “severe cognitive decline”. 
Process data showed that the fidelity of the intervention (the degree to which the 
intervention was delivered as intended) differed between SCUs [30]. Differences between SCU’s 
regarding fidelity will likely influence effectiveness of the intervention. Therefore, fidelity was 
conceptualized into an implementation score consisting of three components. A score was 
calculated for the step detection based on the number of times the step was completed with 
regard to the number of residents residing on the SCU (score 2 if used at least once every six 
months for 75-100% of all residents, score 1 if used for 50-74% , score 0 if used in  < 50%) [30]. In 
addition, the NH staff rated the percentages of cases with challenging behavior in which they 
worked according to the care program on a questionnaire. A score was assigned to each SCU 
based on their answers (score 2 if used in 75-100% of the cases, score 1 if used in 50-74%, score 
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0 if used in  < 50%). At last, two authors closely involved in the implementation (J. D. and B. A.) 
separately rated the implementation based on their communication with the SCUs (at least 
once every six months by telephone or email) about the progress of the implementation (rang-
ing from 0-2, with a higher score indicating a higher degree of implementation). Disagreements 
were solved by discussion. The scores on the three components were summed, resulting in a 
total implementation score (ranging from 0 – 6). 
Statistical analysis
All analyses were performed using the Statistical Package for the Social Sciences (SPSS) 
version 22. Demographic variables of the NH residents at time of enrolment in the study 
were described by means or proportions. Before analysis, all data were checked for missing 
values. In the case of missing values, no data was imputed.
Multilevel model analyses were used to adjust for the clustering of residents in 
the thirteen different SCUs and the correlation of the repeated measures within the  
residents. The CMAI factor scores were checked for normality. The twelve symptom scores 
on the NPI-NH were dichotomized into clinical relevant symptoms (symptom score ≥ 4) or 
no clinical relevant symptoms (symptom score <4). Data on PDU was also dichotomized  
(present or absent) for each category (antipsychotics, anxiolytics, hypnotics, antidepressants, 
anti-epileptics, anti-dementia drugs, any psychotropic medication). In case of binary variables  
(like NPI-NH clinical relevant symptom scores and PDU), the fit for logistic and linear mixed 
model logistic regression were explored by comparing the observed and predicted profiles 
of SCUs over time. In the case of an equal or better fit, we used linear regression instead of 
logistic regression as this allows a direct interpretation in terms of change of percentage 
over time. ICCs were calculated from the variances at the three levels as follows: 
In a previous study evaluating the effect of the intervention in LOD (on which our 
intervention was based on), dementia severity and time being exposed to the intervention had 
an influence on the intervention effect [25]. In addition, differences in fidelity between SCUs 
could influence the intervention effect [30]. Therefore, to investigate whether the intervention 
effect was different for residents with more advanced dementia (GDS score <5 mild, score 
= 5 moderate, score ≥6 severe), or different for residents exposed to the intervention for a 
longer period of time (0-6 months, 6-12 months, 12-18 months), or different for a higher fidelity 
(implementation score), interaction effects between the intervention and these variables were 
investigated. In all analyses, a p value <0.05 was considered statistically significant.
ICC assesment =  var scu + var resident and ICC resident = var scu
 var scu + var resident + var assessment  var scu + var resident
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Results
In total, 274 NH residents with YOD participated in this study. At time of inclusion, mean 
age was 64 years, and the male to female ratio was approximately equal (Table 2).  
The mean length of stay at the SCU was 28 months. The majority of residents (62.8%)  
had severe dementia. Most residents were diagnosed with AD (43.8%), followed by  
frontotemporal dementia (29.2%). One hundred and thirty-one residents participated 
in all assessments. Seventy-six residents were lost to follow-up because they moved to 
another care unit or deceased before the end of the study. Sixty-seven newly admitted 
residents were included after T0. Of the newly admitted residents after T0, baseline data on 
the outcome variables was not available in all cases. Those residents could at time of first 
assessment already have been exposed to the intervention for some months, depending 
on which group the SCU was assigned to (Table 1). Therefore, the number of residents with 
baseline data on outcome variables (n = 227) (Table 3) is lower compared to the number 
of residents participating in the study (n = 274) (Table 2). The most prevalent types of NPS 
(NPI-NH) were agitation/aggression and apathy. Sixty-seven percent used at least one  
psychotropic drug, with antidepressants being the most prevalent type (35.2%). 
Table 2. Demographic and clinical characteristics of the nursing home residents at 
time of inclusion (n = 274).
Age Mean (SD) 
[Range]
63.86 (5.91) 
[39-78]
Gender Male n (%) 138 (50.40)
Length of stay at the SCU (months)a Mean (SD) 
[Range]
28.65 (32.10) 
[1-259]
Dementia severity (GDS)b n (%)
    Mild (2,3,4) 43 (15.70)
    Moderate (5) 57 (20.80)
    Severe (6,7) 172 (62.80)
Dementia subtype n (%)
    Alzheimer’ disease 120 (43.80)
    Vascular dementia 29 (10.60)
    Frontotemporal dementia 80 (29.20)
    Mixed Alzheimer/vascular 14 (5.10)
    Lewy Body/ Parkinson 5 (1.8)
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    Alcohol related dementia 6 (2.20)
    Other 20 (7.30)
a 5 missing
b 1 missing
SD = Standard Deviation; SCU = Special Care Unit; GDS = Global Deterioration Scale
Table 3. Baseline data on outcome variables at the time of inclusion (n=227).
CMAI factor scores Mean (SD)
   Physically aggressive behaviors 13.02 (6.41)
   Physically nonaggressive behaviors 14.86 (7.90)
Verbally agitated behaviors 8.46 (5.90)
Clinical relevant NPI-NH n (%) with  
Mean FxS (SD)
Delusions 29 (12.80) 
8.45 (2.87)
Hallucinations 29 (12.80) 
6.86 (3.01)
Agitation/Aggression 95 (41.90) 
7.27 (2.80)
Depression 42 (18.50) 
7.29 (3.08)
Anxiety 33 (14.50) 
8.18 (3.02)
Euphoria 23 (10.10) 
8.04 (3.14)
Apathy 93 (41.00) 
8.52 (3.28)
Disinhibition 69 (30.40) 
8.07 (3.00)
Irritability 84 (37.00) 
7.63 (2.63)
Aberrant motor behavior 89 (39.20) 
8.47 (3.30)
Nighttime behavior disturbances 37 (16.30) 
7.57 (2.97)
Eating disturbances 43 (18.90) 
7.56 (2.86)
Table 2 (no. 114) continued
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PDU n (%)
Antipsychotics 71 (31.30)
Anxiolytics 60 (26.40)
Hypnotics 34 (15.00)
Antidepressants 80 (35.20)
Anti-epileptics 22 (9.70)
Anti-dementia drugs 12 (5.30)
Any psychotropic medication 152 (67.00)
SD = Standard Deviation; Mean F x S = mean frequency x severity scores of clinically  
relevant NPI-NH scores; PDU = psychotropic drug use
Only the scores for residents included at T0 and residents included at T1 or T2 which not 
yet had been exposed to the intervention are shown.
For all variables (including binary variables), linear regression models were used because 
these models had a better or equally good fit. The analyses showed no significant effect of 
the intervention on physically aggressive behaviors, physically non-aggressive behaviors, 
and verbally agitated behaviors (Table 4.). Additionally, no effect of the intervention on 
other NPS was found. A trend towards a decrease in the use of antidepressants after  
implementation of the intervention was found (Table 4). 
Table 4. Effects of the intervention on NPS and PDU. 
Estimate P 95% CI ICC ICC
Lower 
bound
Upper 
bound
Assess- 
ment
Resi-
dent
CMAI factor scores
Physically non- 
aggressive behaviors
-.137 .825 -1.358 1.074 .616 .023
Physically  
aggressive behaviors
.495 .303 -.448 1.438 .681 .030
Verbally agitated 
behaviors
-.176 .697 -1.065 .713 .641 .011
Clinically relevant  
NPI-NH
Delusions -.048 .136 -.111 .015 .104 .041
Hallucinations .044 .135 -.014 .101 .094 .044
Table 3 (no. 114) continued
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Agitation/aggression -.001 .975 -.090 .087 .238 .108
Depression .022 .560 -.052 .096 .137 .052
Anxiety .034 .318 -.033 .102 .123 .053
Euphoria .031 .338 -.033 .095 .104 .034
Apathy .051 .320 -.051 .154 .240 .077
Disinhibition .077 .092 -.013 .167 .191 .066
Irritability- .000 .999 -.087 .087 .230 .099
Aberrant motor  
behavior
.049 .284 -.041 .139 .236 .110
Nighttime behavior 
disturbances
.050 .180 -.023 .122 .034 .239
Eating disturbances .044 .253 -.031 .118 .156 .071
PDU
Antipsychotics -.002 .956 -.064 .060 .225 .171
Anxiolytics -.033 .301 -.095 .029 .188 .133
Hypnotics -.021 .459 -.078 .035 .118 .070
Antidepressants -.057 .066 -.117 .004 .118 .070
Anti-epileptics .029 .126 -.008 .067 .109 .097
Anti-dementia drugs -.005 .781 -.045 .044 .047 .029
Any psychotropic 
medication
-.023 .505 -.090 .044 .222 .163
PDU = psychotropic drug use
No significant interaction effects between dementia severity and fidelity and the intervention 
effect were found. A significant interaction effect for the effect of the intervention and the 
time that a resident was exposed to the intervention with regard to the prevalence of  
delusions was found (p = .024). After being exposed for a longer period of time to the  
intervention it became more effective in decreasing delusions, with an estimated  
intervention effect of -.06 (p = .056) for SCUs which worked 0-6 months with the  
intervention to an estimated intervention effect of -.06+2*-.06 (estimated intervention  
effect = -.18, p =0.08) for SCUs working 12-18 months with the intervention.
Table 4 (no. 115) continued
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Discussion
To our knowledge, this is the first study that evaluated the effects of a multidisciplinary 
intervention on the management of NPS in NH residents with YOD on the presence of NPS, 
particularly agitation and aggression, and PDU. The intervention was not more effective in 
reducing agitation and aggression, other NPS, or PDU compared to care as usual. 
In contrast, other studies into the management of NPS in dementia resulted in 
significant reduction of NPS. However, these studies cannot be directly compared to this 
study, because these studies made a preselection of residents with clinical relevant/severe 
NPS (based on a cut-off score or selected by NH staff) [49-52]. The current study is implemented 
on SCU level, which means all residents receive the intervention. Consequently, analysis 
was done on all residents, which might have diluted the possible effects. 
Nonetheless, the intervention for the management of NPS and PDU in LOD, on 
which our intervention was based on, was also implemented on unit level and still  
effectiveness was established [25]. An explanation for the differences in effects between  
the original intervention and the adapted intervention for YOD might be that all  
participating SCUs in our study were recruited through NHs that were affiliated with the 
Dutch YOD Knowledge Center (DKC). This knowledge center aims to improve the quality of 
care for people with YOD by developing specific guidelines, supporting scientific research, 
and implementing research findings in clinical practice. Only care organizations offering  
specialized care for people with YOD are affiliated with the center. Those organizations are 
familiar with the specific needs of younger residents. Therefore, they might have already 
(to some degree) developed effective working methods for the management of NPS in YOD 
before implementation of our intervention [12-14]. Indeed, the process evaluation that was 
performed alongside implementation of the intervention revealed that the NH staff  
experienced overlap between the intervention and their current working methods [30]. 
In addition, steps of the intervention, like detection and tool to monitor PDU, were often 
rated as irrelevant [30]. This suggests that users of the intervention did not expected that 
these steps would be more effective in diminishing NPS and PDU compared to care as usual 
in YOD SCUs. Possibly, in YOD SCUs there was less need for an intervention which structured 
the management of NPS compared to LOD care units. The needs from one setting (LOD care 
units) cannot be completely generalize to another setting (YOD SCUs). During the  
development phase of the intervention, research on the specific needs and context of YOD 
SCUs (like pilot study, focus group with YOD NH staff) could have improved implementation.
Despite adding a tool to the intervention for monitoring PDU, no significant  
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decrease in PDU after implementation of the intervention was found. A possible explanation 
could be that the current policy that favors limiting the prescription of psychotropic drugs, 
has already positively influenced the prescription pattern to some degree, leaving fewer 
room for improvement [53]. Indeed, when comparing the PDU rates in our study (68.6 % using  
at least one drug) with the PDU rates in NH residents with YOD approximately 10 years ago 
(87.6 % using at least one drug), the PDU rates in our study appear considerably lower [4]. 
Our results suggest that after working longer with the intervention, it became 
more effective in decreasing delusions. However, the time that a resident was exposed to 
the intervention did not have an influence on the intervention effect for other NPS. Not 
even a trend towards in- or decreasing effectiveness was found for other NPS. Therefore, 
we expected that this interaction effect might have been a result of multiple testing.
 This study has several strengths. We were able to include a large sample size of 
NH residents, resulting in sufficient study power. This is an advantage especially in research 
on YOD, because the prevalence of NH residents with YOD is much lower compared to LOD. 
Moreover, besides effect analysis, a process evaluation was performed to provide qualitative 
data about validity, the implementation strategy, and contextual factors affecting  
implementation [30]. This process information provided important knowledge about which 
factors needed to be taken into account during effect analysis. Furthermore, it helped to 
understand why the intervention was ineffective and which adaptations have to be made 
to increase relevance and fidelity of the intervention [31, 54]. Also, some limitations of this 
study should be considered. The presence of NPS was based on observations of nurses who 
could not be blinded. Awareness of being in the intervention or control condition might have  
influenced their ratings to some degree. Furthermore, no assessment instruments are 
available which take into account the specific characteristics of younger individuals with 
dementia. Therefore, we chose to measure NPS with assessment instruments (NPI-NH, 
CMAI) designed and validated for the use in NH residents with LOD [41, 43]. However,  
especially the CMAI does not extensively assess behavior associated with frontal lobe 
dysfunction, which might be more likely to occur in younger NH residents with dementia 
because of the higher prevalence of FTD [1]. Therefore, some caution should be used when 
interpreting our findings. 
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Conclusions 
The intervention was not more effective in reducing agitation and aggression, other NPS, 
or PDU compared to care as usual. The perceived overlap between the intervention and 
their current working methods and the lower PDU rates compared to approximately 10 
years ago, suggests that YOD SCUs have already (to some degree) developed effective 
working methods for structuring the management of NPS in YOD before implementation 
of our intervention, diminishing the intervention effect. In future studies, more research on 
the specific needs and context of YOD SCUs during the development phase of an interven-
tion is important to improved relevance and effectiveness of an intervention in this specific 
context.
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Chapter 7 
GENERAL DISCUSSION
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This thesis is part of the BEYOND-II study. In this study, a multi-component intervention for the 
management of neuropsychiatric symptoms (NPS) in institutionalized people with  
young-onset dementia (YOD) was developed. The aim of this thesis was to provide knowledge 
to further improve specialized long-term care for people with YOD. The first part of this thesis 
focuses on consequences of NPS for the quality of life (QoL) of residents with YOD and  
differences in NPS between residents with YOD and late-onset dementia (LOD) (Chapters 2 and 
3). In the second part of this thesis, the development, implementation process, and effects of 
the intervention on NPS and psychotropic drug use (PDU) are described (Chapters 4, 5, and 6). 
This general discussion provides a summary of the main findings of this thesis. Methodological 
considerations will be discussed. In addition, the findings of this thesis will be considered 
within the context of daily practice and recommendations for future research will be given. 
Summary of the main findings
1. What are the determinants of quality of life of NH residents with YOD and are there 
differences between dementia subtypes regarding these determinants? 
We found that residents’ QoL was negatively associated with advanced dementia, PDU,  
agitation and aggression, depression, and apathy. In addition, aspects of QoL differed by  
dementia subtype. Residents with FTD showed fewer negative emotions, were more inclined  
to accept help, experienced better quality of relationships with professional caregivers, had 
a more positive self-image, and felt more comfortable in the NH environment compared to 
residents with AD or vascular/mixed dementia. On the contrary, residents with FTD  
appeared to experience a lower quality in their social relationships. 
2. Are there differences in NPS between NH residents with YOD and LOD and can 
these possible differences be attributed to differences in dementia subtype, gen-
der, psychotropic drug use, or dementia severity?
No differences in NPS rates between NH residents with YOD and LOD were found, except for 
apathy. Furthermore, higher levels of PDU in YOD compared to LOD were found, irrespective 
of the presence of NPS.
3. Are internal and external validity of a multi-component intervention for the man-
agement of NPS in NH residents with YOD sufficient and what are barriers and 
facilitators for implementation of the intervention?
A process evaluation showed sufficient internal and external validity, allowing for further 
effect analyses of the intervention for the management of NPS in YOD. Staff turnover and 
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shortages, organizational changes, lack of involvement in the educational program, and 
overlap with current working methods were perceived as important barriers for  
implementation by the multidisciplinary team. Facilitators that were mentioned involved 
multidisciplinary collaboration, limited involvement in other projects, openness to change 
in working procedures, and the support of the ambassador and management. Despite an 
enhanced implementation strategy aimed at overcoming barriers already identified in  
previous implementation studies [1-3], in none of the SCUs all steps of the intervention 
were completely carried out as planned.
4. What is the effect of a multi-component intervention on the prevalence of NPS 
(particularly agitation and aggression) and PDU in residents with YOD compared 
to care as usual? 
No decrease in agitation and aggression, other NPS, and PDU was found after implementation  
of the intervention. Overlap between the intervention and working methods already used 
before implementation, might have diminished the intervention effect. 
Methodological considerations 
Some methodological considerations of this study should be discussed. To be able to  
compare our results with earlier studies on YOD (the Beyond study and the NeedYD study) 
[4, 5], we excluded residents with a symptom onset after the age of 65, traumatic brain 
injury, Korsakov syndrome, Huntington’s disease, human immunodeficiency virus (HIV), 
or Down syndrome. However, there is no international consensus on the definition of YOD 
[6]. The cut-off at age 65 is considered arbitrary as this is only based on the social division 
in terms of employment and retirement age. Other differences between younger and older 
people with dementia (like differences in social network, family structure, vitality, etiology) 
are not taken into account [6]. In order to provide consensus on an operational definition 
of YOD, the Prevalence REcognition and Care pathways in young Onset Dementia (Precode) 
study recently started [7]. Also, admission criteria for YOD SCUs differ between health care 
organizations. In some YOD SCUs a YOD diagnosis is not a requirement for admission. 
Placement depends on other factors like social characteristics or somatic care needs. 
Consequently, in some of the participating SCUs in this study less than fifty percent of the 
residents were eligible for inclusion. Therefore, we should be aware that the results of this 
study cannot be generalized to all people residing on YOD SCUs. 
Furthermore, we did not perform all steps from the Medical Research Council (MRC) 
framework as a guide for adapting the original intervention for the use in YOD SCUs [8].
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Information on perceived barriers and facilitators for implementation found in previous 
studies on LOD units was used to develop the intervention and implementation strategy 
in this study [1-3]. However, during the course of the study we became aware that results 
from one setting (LOD care units) could not be transferred to another setting (YOD SCUs) 
completely. For example, in our study overlap between the intervention and current  
working methods was mentioned as a barrier for implementation, while the LOD NH staff 
did not experience this particular barrier. This implies that YOD SCUs were more inclined to 
already, at least to some degree, use a structured working method for the management of 
NPS, limiting the relevance of some steps of the intervention. According to the MRC  
framework, additional research on the specific context of YOD SCUs (like interviews, a pilot 
study, or a focus group with YOD NH staff) during the development phase of the  
intervention and the development of the implementation strategy, could have further  
improved the relevance and fidelity of the intervention in this specific context [8]. 
At last, The Dutch National Health Care Institute, which determines and advises  
on in- and exclusion of different types of health care in the basic care package, wrote a 
report on the complexity of establishing effect of an intervention in long-term care [9]. 
Although a randomized controlled trial (RCT) is widely considered as the golden standard 
for providing evidence for the effectiveness of clinical trials and is the best method to 
minimize selection bias and to determine intervention effects, it is important to take into 
account its limitations for complex interventions in long-term care [9,10]. The intervention 
in this thesis can be considered complex because of the different interacting components 
of the intervention (five-step care program and the educational program) and the diversity 
in NH staff members using the intervention [8] (Chapter 4). First, in RCTs contextual factors 
are often perceived as influences that need to be controlled for, in order to isolate the  
intervention effect [9]. A RCT does not examine how complex interventions interact within 
the context in which they are implemented and received [11]. However, according to the 
realism approach, contextual factors are part of daily practice and therefore RCT’s often 
do not reflect the real clinical environment. Realists state that it is not the intervention 
by itself, but the interaction of the intervention with the context that is the core of change 
[10]. Therefore, contextual information is necessary to understand why an intervention was 
(in)effective in a specific setting and to successfully reproduce the intervention in another 
setting. In order to overcome this limitation, along with effect analysis a process evaluation 
was performed to provide qualitative data about the implementation strategy and  
contextual factors affecting implementation (Chapter 5). Secondly, RCTs fail to understand 
the effects of intervention components separately in order to make conclusions about 
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which specific intervention components are effective within a context and which specific 
components are redundant or need adjustment [11]. This could be resolved by using  
multi-arm studies in which various steps of the intervention are investigated in different 
arms [10]. However, this approach only works if the intervention components are  
non-interacting, which was not the case in our study [10]. In order to be able to provide 
some information about the specific intervention components in this study, qualitative 
data about the relevance and feasibility perceived by the users of the intervention of each 
step of the intervention was collected (Chapter 5). This information provided important 
insight into the adaptations which have to be made to increase relevance and fidelity of 
the intervention. Thirdly, RCTs are perceived to be double-blinded: neither NH staff nor 
residents should be aware if they are in the control or intervention condition. However, this 
assumption is often violated in a complex intervention in long-term care [9, 11]. Also, in this 
study, NH staff was aware that they were in the intervention condition because that  
condition required working with the intervention. To minimize bias, no feedback was given 
to the nurses during the assessments regarding the scores on the outcome measures.  
To overcome lack of blinding in future complex intervention studies, a solution could be to 
assess the outcome variables with observations of research assistants blind to intervention 
allocation. Furthermore, the use of a factorial design, in which SCUs are randomly allocated  
to one or more interventions simultaneously using various combinations of interventions, 
makes it more straightforward to maintain blinding [12, 13]. 
Clinical implications
This thesis provides important clinical implications for care giving in NH residents with 
YOD and future implementation of interventions in NHs. The higher rates of apathy in 
YOD (Chapter 3) raise concern because of the strong association with QoL of the residents 
(Chapter 2). Moreover, apathy has found to be an important predictor for institutionalization, 
has been found related to mortality of NH residents with dementia, and has been found  
associated with high levels of informal caregiver distress in community-dwelling people 
with dementia [14-16]. Although not yet investigated, it is expected that the same  
association between apathy and distress applies to informal caregivers of NH residents 
with dementia. These results underscore the need for adequate detection and treatment 
of apathy especially in residents with YOD. Despite the increased interest in the treatment 
of apathy in dementia, results of intervention studies in LOD are inconsistent and still no 
effective treatment has yet been established [17-20]. However, the results of cognitive  
stimulation and activation strategies on apathy in dementia are promising [21-22],  
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suggesting that proving mentally stimulating activities can decrease apathy. Research in 
community-dwelling people with YOD found that a feeling of being engaged and feeling 
useful is important when offering activities to people with YOD [25]. Therefore, household 
activities, work-related activities, and social activities might be important to at least  
community-dwelling people with YOD. This is in line with the concept of social health 
which focuses on the capacity and potential of the person with dementia in order to  
prevent disengagement and improve self-manage, instead of focusing on symptoms and 
disability [24, 25]. Important research has been done on social health in NH residents with 
LOD providing new opportunities for people with dementia to participate in social life 
[26, 27]. More research is needed to explore what type of activities meet the needs of NH 
residents with YOD and to investigate the effects of activities on decreasing apathy. Also, 
to increase awareness and insight in apathy in NH residents with YOD, in the detection of 
NPS in clinical practice and in future research on YOD apathy should be more extensively 
assessed by using specific tools like the Apathy Evaluation Scale [28].
The heterogeneity of the YOD NH population implies that a distinction between 
placement on a YOD or LOD unit purely based on age of symptom onset (before or after the 
age of 65) is an oversimplification. The high proportions of less common causes of dementia 
in YOD (such as FTD) with different care needs with regard to QoL (Chapter 2) and the highly 
variable age of NH residents with YOD [range 39-78 years] demands flexibility in care skills, 
day time activities, support, and physical environment. By placing people on a YOD SCU 
only based on age of symptom onset, the resident’s individual care needs might be  
overlooked. Over the last decade, several Dutch NHs introduced sociotherapeutic living  
environments. In a sociotherapeutic living environment, the supply of care, therapeutic 
guidance, daily activities and housing are methodically coordinated, in order to achieve 
the best possible quality of life. Within one care-organization different living groups can  
be organized, based on residents’ social, psychological and physical care needs [29].  
The Dutch YOD Knowledge Center (DKC) already acknowledges the importance of  
sociotherapeutic living environments and facilitates the use by providing a guideline for 
the implementation on YOD SCUs [30]. However, no research has been done on the  
effectiveness of sociotherapeutic living environments in clinical practice. Currently, the 
Netherlands Organization for Health Research and Development provides funding to  
optimize implementation and investigate the effect of sociotherapeutic living environments  
in Dutch NHs on QoL, NPS, and PDU in residents with dementia (LIVE-study-ZonMW project 
number 733050708) [31]. The results of this study might be useful to also further improve 
individualized care in residents with YOD.
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Furthermore, our results raise awareness of the difficulties with implementation 
of standardized complex intervention within different settings. In none of the YOD SCUs all 
steps of the intervention were completely carried out as planned. Other implementation 
studies in NHs also faced implementation barriers [6, 7, 11, 32, 33]. Although standardized  
interventions and protocols provide a definition of good quality of care, enable evidence-based  
treatment, and facilitate comparison of quality of care between services, they are unable to 
take into account all contextual influences. For example, on some small-scale units or units 
with a low nursing staff-resident ratio, it was impossible to fill in the analysis of NPS (step 
of the intervention) with a colleague like the intervention prescribes, therewith hindering 
implementation. A second-best solution to improve quality of care could be to allow for 
more customization of the intervention to the contexts of a specific settings. This can be 
achieved by performing participatory action research (PAR) [34]. In PAR the participants (in 
this study NH staff) would be actively involved in the collection and analysis of data about 
the specific context. Based on this information the participants determine which actions 
should follow. Experiences from a PAR study on improving antimicrobial prescribing showed  
that participants appreciated being involved in the development and implementation of 
an intervention. Also, in this study different interventions were selected by the participants 
for different settings, which strengthens the assumption that a ‘one size fits all’ approach  
is not the best solution to improve quality of care [35]. A recent example of PAR in the  
management of NPS in dementia is ‘the Reduction of Inappropriate psychotropic Drug use 
in NH residents with dementia (RID) study’, in which for each NH the prescription pattern of 
psychotropic drugs was analyzed together with the NH staff [36]. Researchers provided a 
list of several possible interventions for optimizing the prescription pattern. Based on their 
analysis, the NH staff chose which intervention had the most potential in the specific  
context of their NHs. The results of this study are expected in 2019. 
Currently, a similar discussion about the feasibility of implementing standardized 
interventions and protocols within different contexts arose when the Dutch government 
presented a plan of action to improve the quality of NH care in the Netherlands [37].  
Although there was agreement on the conditions necessary to provide good care between 
NHs, like person-centered care, professional education and training, safety, learning and 
improving, sufficient and competent NH staff, NH staff asked for more flexibility in the 
methods to accomplish these conditions. The plan of action restricted the NH staff to  
develop working methods that suited the specific context of the own organization,  
therewith hindering improvement of care. To address this issue, the Dutch Ministry of 
Health, Welfare, and Sport (VWS) supported a pilot called ‘Radicale Vernieuwing’ in which 
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fifty-two NHs were allowed to develop their own working methods for good quality of care, 
regardless of current protocols [38]. The results of the pilot of VWS (presented in 2019) will 
provide more insight on the effects of a more flexible approach with regard to protocols 
and interventions on overall quality of NH care. 
Future research directions
Several implications for future research in YOD emerge from the results of this thesis.  
First, more research is needed on adequate treatment of apathy in NH residents with YOD. 
Research on social health in LOD offers a promising starting point for the development 
of interventions which aim to improve social participation and self-manage [24]. More 
research is needed on the specific needs of NH residents with YOD regarding meaningful 
activities and the effects of these activities on the presence of apathy.
Furthermore, because of the heterogeneity of the YOD NH population, in future 
research on YOD there should be more differentiation between YOD and LOD than a  
distinction purely based on age of symptom onset. A solution could be to include large 
samples of NH residents with YOD and LOD combined in which subgroups based on age are 
created (for example youngest <45, young <65, old > 65, oldest > 90). Moreover, more  
research on specific subgroups like people with FTD is recommended, like the study of 
Prins and Hendriks on focusing in FTD [39]. 
At last, the lower PDU rates in NH residents with YOD compared to approximately 
10 years ago are promising [5]. However, the current prescription rates of psychotropic 
drugs in NH residents with YOD remain high and seem still higher compared to LOD  
(Chapter 3). This suggests that the threshold for the use of psychotropic drugs in the  
management of NPS maybe lower in YOD compared to LOD. An explanation could be that 
NPS in younger individuals are perceived as more threatening or distressing by the nursing 
staff. Consequently, physicians might be more inclined to prescribe psychotropic drugs in 
YOD than in LOD [40]. Indeed, a recent study on the association between NPS and nursing 
staff distress in YOD and LOD showed that LOD nurses less often appeared to experience 
high levels of distress [41]. Another explanation could be that physicians are more concerned  
for poor health outcomes associated with PDU (like stroke, increased mortality) in older 
people with dementia [42,43]. In order to understand the differences in prescription pattern  
between YOD and LOD and therewith be able to further improve the psychotropic drug 
prescription pattern in YOD, research on the factors associated with PDU in YOD is needed.
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Conclusions 
This thesis provides valuable knowledge to further improve specialized long-term care for 
people with YOD. With regard to the determinants of QoL and presence of NPS there are a 
lot of similarities between NH residents with YOD and LOD, suggesting that NH residents 
with YOD and LOD should not be treated as two completely separate entities. Nonetheless, 
higher rates of apathy and its negative influence on QoL underscore the need for adequate 
detection and treatment of apathy especially in NH residents with YOD. Furthermore, the 
heterogeneity of the YOD NH population with regard to etiology and age demands flexibility  
in care skills, day time activities, support, and physical environment to meet the large  
variety in needs. In order for the NH staff to be able to address this large diversity of care 
needs of all residents with YOD, placement on a specific unit should depend on more  
factors then age of disease onset by itself.
With regard to establishing effectiveness of a complex intervention in daily  
practice, this thesis underscores the need for collecting qualitative data (focus groups, 
interviews, pilot study) in addition to quantitative data (RCT). Qualitative data in the  
development phase of the intervention and implementation strategy is necessary to attune 
the intervention to needs and context of a specific setting therewith improving relevance 
and fidelity of the intervention. In addition, qualitative data can provide knowledge about 
which specific intervention components are effective and which specific components are 
redundant or need adjustment. Moreover, qualitative data is necessary to understand how 
an intervention works within a context and how the context affects implementation. 
At last, we should be aware of the difficulties for implementation of protocols 
and interventions in the context of daily practice. We should consider the feasibility of  
completely carrying out a standardized protocol or intervention as planned within different 
contexts. Implementation and effectiveness could improve by allowing for more  
customization of the intervention to the context of a specific setting. 
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Summary
Neuropsychiatric symptoms (NPS), like aggression, apathy, hallucinations, and depression 
occur in almost all nursing home (NH) residents with young-onset dementia (YOD); defined  
as dementia with a symptom onset before 65 years. As in late-onset dementia (LOD),  
psychotropic drugs are often used in the treatment of NPS in NH residents with YOD.  
The prevalence rates of NPS and psychotropic drug use (PDU) seem higher compared to 
those in NH residents with LOD, but studies directly comparing NPS in heterogeneous  
samples of NH residents with YOD and LOD are still lacking. In NH residents with LOD, NPS 
and PDU are associated with a loss of quality of life of the NH resident. However, to our 
knowledge no studies on the influence of NPS and PDU on quality of life of NH residents 
with YOD have been conducted. 
The high rates of NPS and PDU stresses the need for non-pharmacological  
interventions especially in the management of NPS in YOD. Therefore, in the Behavior and 
Evolution of Young ONset Dementia part 2 (BEYOND-II) study a multi-component  
intervention for the management of NPS in NH residents with YOD was developed and im-
plemented in YOD special care units (SCUs). This thesis is part of the Beyond-II study and 
the methodology of the Beyond-II study is discussed in chapter 4. The general aim of this  
thesis is to provide knowledge to further improve specialized long-term care for people 
with YOD. This thesis focuses on consequences of NPS and PDU for the quality of NH  
residents with YOD and differences in NPS between NH residents with YOD and LOD. In 
addition, the implementation process and effects of the multi-component intervention for 
the management of NPS in YOD on the prevalence of NPS and PDU in YOD are evaluated. 
In the introduction of this thesis (chapter 1) background information on YOD, 
the study rationale, and the research questions are described. In chapter 2, the determinants  
of quality of life of NH residents with YOD are explored. In addition, it is investigated if these 
determinants differed between dementia subtypes. Residents’ quality of life is negatively 
associated with advanced dementia, PDU, agitation, aggression, depression, and apathy. 
In addition, aspects of quality of life differ by dementia subtype. Residents with FTD show 
less negative emotions, accept more help and experience better quality of relationships 
with professional caregivers, have a more positive self-image, feel more comfortable in the 
NH environment, and experience lower quality of social relationships compared to residents 
with Alzheimer and vascular/mixed dementia. 
In chapter 3, the differences in NPS between heterogeneous samples of NH  
residents with YOD and LOD are investigated. In addition, it is explored if these possible  
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differences could be attributed to differences in dementia subtype, gender, psychotropic 
drug use, or dementia severity. Higher rates of apathy are found in NH residents with YOD 
compared to LOD. No differences in other NPS between YOD and LOD are found.  
Furthermore, higher levels of PDU in YOD compared to LOD are found, irrespective of the 
occurrence of NPS. 
In order to interpret the effects of the intervention for the management of NPS 
specifically in YOD, information on validity and degree of implementation is important. 
Furthermore, implementation knowledge is important to optimize implementation  
strategies for future complex interventions in applied NH care. Therefore, in chapter 5, 
a process evaluation is performed. The process evaluation shows sufficient internal and 
external validity, allowing for further effect analyses of the intervention. Staff turnover and 
shortages, organizational changes, lack of involvement in the educational program, and 
overlap with current working methods are perceived as important barriers for  
implementation by the multidisciplinary teams. Facilitators that are mentioned involved: 
multidisciplinary collaboration, limited involvement in other projects, openness to change 
in working procedures, and the support of the ambassador and management. In none of the 
SCUs all steps of the intervention are completely carried out as planned. Recommendations  
for future implementation are integration of the intervention in the electronic health  
records, allowing for customization of the intervention to the context of a specific setting, 
and taking into account the aspect of readiness to change of users of the intervention in 
the development and implementation strategy. 
 In chapter 6, the effect of the multi-component intervention on the prevalence of 
NPS, with agitation and aggression in particular, as well as PDU in NH residents with YOD 
is compared to care as usual. No decrease in agitation and aggression, other NPS, or PDU 
is found after implementation of the intervention. Overlap between the intervention and 
working methods already used before implementation, might have diminished the  
intervention effect. In future research, more research on the specific needs and context of 
YOD SCUs during the development phase of an intervention is important to improved  
relevance and effectiveness of an intervention in this specific context.
 In chapter 7, methodological considerations of this thesis are discussed. The  
findings are considered within the context of daily practice. In addition, recommendations 
for future research are addressed. 
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Samenvatting
We spreken van dementie op jonge leeftijd wanneer de eerste verschijnselen van de  
dementie voor het 65e levensjaar zijn aangevangen. Probleemgedrag, zoals agressie, angst, 
hallucinaties, apathie en depressie, komt bij bijna alle verpleeghuisbewoners met dementie 
op jonge leeftijd voor. Net als bij de behandeling van probleemgedrag bij oudere mensen 
met dementie, worden bij jonge mensen met dementie vaak psychofarmaca voorgeschreven. 
De prevalentie van probleemgedrag en psychofarmacagebruik bij verpleeghuisbewoners 
met dementie op jonge leeftijd lijkt hoger dan bij oudere verpleeghuisbewoners met  
dementie. Dit is echter nog niet eerder onderzocht in heterogene studiepopulaties van 
verpleeghuisbewoners met dementie op jonge en oudere leeftijd. Bij oudere  
verpleeghuisbewoners met dementie hangt de aanwezigheid van probleemgedrag en  
psychofarmacagebruik samen met een slechtere kwaliteit van leven. Er zijn nog geen  
studies gedaan naar de invloed probleemgedrag en psychofarmacagebruik op de kwaliteit 
van leven van verpleeghuisbewoners met dementie op jonge leeftijd. 
De hoge prevalenties van probleemgedrag en psychofarmacagebruik bij  
verpleeghuisbewoners met dementie op jonge leeftijd benadrukken het belang van effectieve 
niet-medicamenteuze interventies voor probleemgedrag. Om deze reden is in de Behavior 
and Evolution of Young ONset Dementia part 2 (BEYOND-II) studie een interventie  
ontwikkeld speciaal voor de behandeling van probleemgedrag bij verpleeghuisbewoners 
met dementie op jonge leeftijd. Deze interventie is geïmplementeerd op gespecialiseerde  
verpleeghuisafdelingen voor mensen met dementie op jonge leeftijd verspreid over Nederland. 
Dit proefschrift is onderdeel van de Beyond-II studie. De methodologie van deze 
studie wordt beschreven in hoofdstuk 4. De centrale doelstelling van dit proefschrift is het 
verbeteren van de gespecialiseerde verpleeghuiszorg voor jonge mensen met dementie. 
Het eerste deel van dit proefschrift richt zich op de consequenties van probleemgedrag en 
psychofarmacagebruik voor de kwaliteit van leven van verpleeghuisbewoners met  
dementie op jonge leeftijd en de verschillen in probleemgedrag tussen verpleeghuisbewoners 
met dementie op oudere en jongere leeftijd. In het tweede deel van dit proefschrift wordt 
het effect van de interventie voor probleemgedrag bij verpleeghuisbewoners met dementie 
op jonge leeftijd op de aanwezigheid van probleemgedrag en psychofarmacagebruik  
geëvalueerd. 
In de introductie van dit proefschrift (hoofdstuk 1) wordt achtergrondinformatie 
over dementie op jonge leeftijd geven en worden de rationale en vraagstellingen van dit 
proefschrift beschreven. In hoofdstuk 2 worden determinanten van kwaliteit van leven van 
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verpleeghuisbewoners met dementie op jonge leeftijd onderzocht. Daarnaast wordt  
gekeken of deze determinanten verschillen tussen dementie subtypes. Verder gevorderde 
dementie, psychofarmacagebruik, agitatie, agressie, depressie en apathie zijn van negatieve  
invloed op kwaliteit van leven van verpleeghuisbewoners met dementie op jonge leeftijd. 
Daarnaast wordt er verschil gevonden op aspecten van kwaliteit van leven tussen dementie 
subtypes. Verpleeghuisbewoners met frontotemporale dementie laten minder negatieve  
emoties zien, zijn meer bereid om hulp te accepteren, ervaren een betere kwaliteit van de 
relaties met professionele zorgverleners, hebben een beter zelfbeeld en voelen zich meer 
op het gemak in de verpleeghuisomgeving in vergelijking met verpleeghuisbewoners met 
Alzheimer of vasculaire/gemengde dementie. Daarentegen ervaren verpleeghuisbewoners 
met frontotemporale dementie een lagere kwaliteit van sociale relaties.
In hoofdstuk 3 worden de verschillen in probleemgedrag tussen  
heterogene studiepopulaties van verpleeghuisbewoners met dementie op jonge en oudere 
leeftijd onderzocht. Apathie komt veel vaker voor bij verpleeghuisbewoners met dementie 
op jonge leeftijd. Er wordt geen verschil gevonden in de aanwezigheid van andere vormen 
van probleemgedrag. Toch wordt er wel meer psychofarmaca voorgeschreven bij verpleeg-
huis bewoners met dementie op jonge leeftijd. 
In hoofdstuk 5 worden de resultaten van de procesevaluatie beschreven. Inzicht 
in validiteit en mate van implementatie is belangrijk om de effecten van de interventie te 
kunnen interpreteren. Daarnaast draagt implementatiekennis bij aan het verder  
optimaliseren van implementatiestrategieën in toekomstige implementatiestudies. Uit de 
procesevaluatie komt naar voren dat interne en externe validiteit voldoende zijn, waardoor 
effectanalyse mogelijk is. De mate van implementatie wisselt tussen verpleeghuisafdelingen  
en implementatie is in geen één verpleeghuisafdeling optimaal. Wisselingen in personeel, 
personeelstekorten, organisatorische veranderingen, beperkte betrokkenheid in het  
scholingsprogramma en overlap met huidige werkwijzen worden als belemmerend ervaren 
voor implementatie. Bevorderend voor implementatie zijn goede multidisciplinaire  
samenwerking, beperkte betrokkenheid in andere (onderzoeks)projecten, openheid tot 
verandering en ondersteuning van een ambassadeur en het management. Voor toekomstige 
implementatie wordt aangeraden om de interventie te integreren in het elektronisch  
cliëntendossier. Daarnaast wordt aangeraden om meer variatie in de uitvoer van de  
interventie toe te staan, zodat er ingespeeld kan worden op de specifieke omgeving van 
een verpleeghuis. Ook is het van belang om bij toekomstige implementatie de gereedheid 
tot verandering van gebruikers van de interventie mee te nemen in de ontwikkeling van de 
interventie en implementatiestrategie.
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In hoofdstuk 6 wordt het effect van de interventie op de aanwezigheid van  
probleemgedrag, met in het bijzonder agitatie en agressie, en psychofarmacagebruik  
vergeleken met standaard dagelijkse zorg. Na implementatie van de interventie wordt geen 
vermindering van agitatie en agressie, andere vormen van probleemgedrag of  
psychofarmacagebruik gevonden. Een verklaring voor het uitblijven van effect kan zijn dat 
de verpleeghuisafdelingen voor mensen met dementie op jonge leeftijd al (gedeeltelijk) 
effectieve werkmethoden hadden voor het structureren van de behandeling van  
probleemgedrag bij verpleeghuisbewoners met dementie op jonge leeftijd voorafgaand 
aan implementatie van de interventie. Mogelijk dat overlap tussen de al bestaande  
werkmethoden en de interventie het interventie effect heeft verminderd. In toekomstige 
onderzoek is het van belang om tijdens de ontwikkeling van de interventie meer aandacht 
te hebben voor de specifieke behoeften en context van verpleeghuisafdelingen voor  
mensen met dementie op jonge leeftijd. Hierdoor kan de relevantie en effectiviteit van de 
interventie verbeterd worden. 
Tenslotte worden in hoofdstuk 7 methodologische aspecten van de studie en 
implicaties van de bevindingen voor de klinische praktijk besproken. Daarnaast worden 
aanbevelingen voor toekomstig onderzoek gedaan.  
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